| Year |
Citation |
Score |
| 2023 |
De Schepper M, Nguyen HL, Richard F, Rosias L, Lerebours F, Vion R, Clatot F, Berghian A, Maetens M, Leduc S, Isnaldi E, Molinelli C, Lambertini M, Grillo F, Zoppoli G, ... ... Vermeulen P, et al. Treatment response, tumor infiltrating lymphocytes and clinical outcomes in inflammatory breast cancer treated with neoadjuvant systemic therapy. Cancer Research Communications. PMID 38147006 DOI: 10.1158/2767-9764.CRC-23-0285 |
0.327 |
|
| 2023 |
Bohlok A, Richard F, Lucidi V, Asmar AE, Demetter P, Craciun L, Larsimont D, Hendlisz A, Van Laethem JL, Dirix L, Desmedt C, Vermeulen P, Donckier V. Histopathological growth pattern of liver metastases as an independent marker of metastatic behavior in different primary cancers. Frontiers in Oncology. 13: 1260880. PMID 37965465 DOI: 10.3389/fonc.2023.1260880 |
0.314 |
|
| 2023 |
Mariani P, Torossian N, van Laere S, Vermeulen P, de Koning L, Roman-Roman S, Lantz O, Rodrigues M, Stern MH, Gardrat S, Lesage L, Champenois G, Nicolas A, Matet A, Cassoux N, et al. Immunohistochemical characterisation of the immune landscape in primary uveal melanoma and liver metastases. British Journal of Cancer. PMID 37443346 DOI: 10.1038/s41416-023-02331-w |
0.523 |
|
| 2023 |
Barnhill R, van Laere S, Vermeulen P, Roman-Roman S, Gardrat S, Alsafadi S, Tarin M, Champenois G, Nicolas A, Matet A, Cassoux N, Servois V, Rodrigues M, Scolyer R, Lazar A, et al. L1CAM and laminin vascular network: Association with the high-risk replacement histopathologic growth pattern in uveal melanoma liver metastases. Laboratory Investigation; a Journal of Technical Methods and Pathology. 102: 1214-1224. PMID 36775447 DOI: 10.1038/s41374-022-00803-w |
0.575 |
|
| 2023 |
Richard F, De Schepper M, Maetens M, Leduc S, Isnaldi E, Geukens T, Van Baelen K, Nguyen HL, Vermeulen P, Van Laere S, Bertucci F, Ueno N, Dirix L, Floris G, Biganzoli E, et al. Comparison of the genomic alterations present in tumor samples from patients with metastatic inflammatory versus non-inflammatory breast cancer reveals AURKA as a potential treatment target. Breast (Edinburgh, Scotland). PMID 36717329 DOI: 10.1016/j.breast.2023.01.010 |
0.681 |
|
| 2022 |
Billiet C, Vingerhoed W, Van Laere S, Joye I, Mercier C, Dirix P, Nevens D, Vermeulen P, Meijnders P, Verellen D. Precision of image-guided spinal stereotactic ablative radiotherapy and impact of positioning variables. Physics and Imaging in Radiation Oncology. 22: 73-76. PMID 35686020 DOI: 10.1016/j.phro.2022.04.006 |
0.475 |
|
| 2022 |
Barnhill R, van Laere S, Vermeulen P, Roman-Roman S, Gardrat S, Alsafadi S, Tarin M, Champenois G, Nicolas A, Matet A, Cassoux N, Servois V, Rodrigues M, Scolyer R, Lazar A, et al. L1CAM and laminin vascular network: Association with the high-risk replacement histopathologic growth pattern in uveal melanoma liver metastases. Laboratory Investigation; a Journal of Technical Methods and Pathology. PMID 35672380 DOI: 10.1038/s41374-022-00803-w |
0.575 |
|
| 2022 |
Dirix L, Buys A, Oeyen S, Peeters D, Liègeois V, Prové A, Rondas D, Vervoort L, Mariën V, Laere SV, Vermeulen P. Circulating tumor cell detection: A prospective comparison between CellSearch® and RareCyte® platforms in patients with progressive metastatic breast cancer. Breast Cancer Research and Treatment. PMID 35397078 DOI: 10.1007/s10549-022-06585-5 |
0.43 |
|
| 2022 |
Roy-Luzarraga M, Reynolds LE, de Luxán-Delgado B, Maiques O, Wisniewski L, Newport E, Rajeeve V, Drake RJG, Gómez-Escudero J, Richards FM, Weller C, Dormann C, Meng YM, Vermeulen PB, Saur D, et al. Suppression of Endothelial Cell FAK Expression Reduces Pancreatic Ductal Adenocarcinoma Metastasis after Gemcitabine Treatment. Cancer Research. 82: 1909-1925. PMID 35350066 DOI: 10.1158/0008-5472.CAN-20-3807 |
0.304 |
|
| 2022 |
Dirix LY, Oeyen S, Buys A, Liégois V, Prové A, Van De Mooter T, Van Laere S, Vermeulen PB. Coagulation/fibrinolysis and circulating tumor cells in patients with advanced breast cancer. Breast Cancer Research and Treatment. PMID 35132503 DOI: 10.1007/s10549-021-06484-1 |
0.675 |
|
| 2022 |
Meyer Y, Bohlok A, Höppener D, Galjart B, Doukas M, Grünhagen DJ, Labar A, Lucidi V, Vermeulen PB, Verhoef C, Donckier V. Histopathological growth patterns of resected non-colorectal, non-neuroendocrine liver metastases: a retrospective multicenter study. Clinical & Experimental Metastasis. 39: 433-442. PMID 35124739 DOI: 10.1007/s10585-022-10153-y |
0.322 |
|
| 2022 |
Rypens C, Bertucci F, Finetti P, Robertson F, Fernandez SV, Ueno N, Woodward WA, Van Golen K, Vermeulen P, Dirix L, Viens P, Birnbaum D, Devi GR, Cristofanilli M, Van Laere S. Comparative transcriptional analyses of preclinical models and patient samples reveal MYC and RELA driven expression patterns that define the molecular landscape of IBC. Npj Breast Cancer. 8: 12. PMID 35042871 DOI: 10.1038/s41523-021-00379-6 |
0.613 |
|
| 2022 |
Lugassy C, Vermeulen PB, Ribatti D, Pezzella F, Barnhill RL. Vessel co-option and angiotropic extravascular migratory metastasis: a continuum of tumour growth and spread? British Journal of Cancer. PMID 34987186 DOI: 10.1038/s41416-021-01686-2 |
0.315 |
|
| 2021 |
Teuwen LA, De Rooij LPMH, Cuypers A, Rohlenova K, Dumas SJ, García-Caballero M, Meta E, Amersfoort J, Taverna F, Becker LM, Veiga N, Cantelmo AR, Geldhof V, Conchinha NV, Kalucka J, ... ... Vermeulen P, et al. Tumor vessel co-option probed by single-cell analysis. Cell Reports. 35: 109253. PMID 34133923 DOI: 10.1016/j.celrep.2021.109253 |
0.591 |
|
| 2021 |
Tabariès S, Annis MG, Lazaris A, Petrillo SK, Huxham J, Abdellatif A, Palmieri V, Chabot J, Johnson RM, Van Laere S, Verhoef C, Hachem Y, Yumeen S, Meti N, Omeroglu A, ... ... Vermeulen P, et al. Claudin-2 promotes colorectal cancer liver metastasis and is a biomarker of the replacement type growth pattern. Communications Biology. 4: 657. PMID 34079064 DOI: 10.1038/s42003-021-02189-9 |
0.641 |
|
| 2021 |
Lindgren M, Jansson M, Tavelin B, Dirix L, Vermeulen P, Nyström H. Type IV collagen as a potential biomarker of metastatic breast cancer. Clinical & Experimental Metastasis. 38: 175-185. PMID 33655422 DOI: 10.1007/s10585-021-10082-2 |
0.37 |
|
| 2020 |
Bohlok A, Vermeulen P, Leduc S, Latacz E, Botzenhart L, Richard F, De Schepper M, Geukens T, Lucidi V, Ignatiadis M, Aftimos P, Sotiriou C, Piccart M, Hendlisz A, Van Laere S, et al. Association between the histopathological growth patterns of liver metastases and survival after hepatic surgery in breast cancer patients. Npj Breast Cancer. 6: 64. PMID 33339824 DOI: 10.1038/s41523-020-00209-1 |
0.624 |
|
| 2020 |
Mercier C, Claessens M, Buys A, Gryshkevych S, Billiet C, Joye I, Van Laere S, Vermeulen P, Meijnders P, Löfman F, Poortmans P, Dirix L, Verellen D, Dirix P. Stereotactic ablative radiation therapy to all lesions in patients with oligometastatic cancers: a phase I dose-escalation trial. International Journal of Radiation Oncology, Biology, Physics. PMID 33307151 DOI: 10.1016/j.ijrobp.2020.11.066 |
0.532 |
|
| 2020 |
Oeyen S, Liégeois V, De Laere B, Buys A, Strijbos M, Dirix P, Meijnders P, Vermeulen P, Van Laere S, Dirix L. Automated enumeration and phenotypic characterization of CTCs and tdEVs in patients with metastatic castration resistant prostate cancer. Prostate Cancer and Prostatic Diseases. PMID 33230201 DOI: 10.1038/s41391-020-00304-1 |
0.579 |
|
| 2020 |
Machiels M, Weytjens R, Erven K, Westerhoff JM, Amrouch S, Bosiers J, Verkinderen L, Hauspy J, van Dam P, Stevens P, Bernaerts A, Strijbos M, Meijnders P, Dirix P, Verellen D, ... ... Vermeulen PB, et al. Oncological outcome, postoperative complications, and mammographic changes after intraoperative radiotherapy with electrons (IOERT) as a boost in a large single-institution cohort of breast cancer patients. The Breast Journal. PMID 32779870 DOI: 10.1111/Tbj.13986 |
0.658 |
|
| 2020 |
Latacz E, van Dam PJ, Vanhove C, Llado L, Descamps B, Ruiz N, Joye I, Grünhagen D, Van Laere S, Dirix P, Mollevi D, Verhoef C, Dirix L, Vermeulen P. Can medical imaging identify the histopathological growth patterns of liver metastases? Seminars in Cancer Biology. PMID 32735852 DOI: 10.1016/J.Semcancer.2020.07.002 |
0.647 |
|
| 2020 |
Buisman FE, van der Stok EP, Galjart B, Vermeulen PB, Balachandran VP, Coebergh van den Braak RRJ, Creasy JM, Höppener DJ, Jarnagin WR, Kingham TP, Nierop PMH, Sadot E, Shia J, Groot Koerkamp B, Grünhagen DJ, et al. Histopathological growth patterns as biomarker for adjuvant systemic chemotherapy in patients with resected colorectal liver metastases. Clinical & Experimental Metastasis. PMID 32691187 DOI: 10.1007/S10585-020-10048-W |
0.358 |
|
| 2020 |
Billiet C, Joye I, Mercier C, Depuydt L, De Kerf G, Vermeulen P, Van Laere S, Van de Kelft E, Meijnders P, Verellen D, Dirix P. Outcome and toxicity of hypofractionated image-guided SABR for spinal oligometastases. Clinical and Translational Radiation Oncology. 24: 65-70. PMID 32642561 DOI: 10.1016/J.Ctro.2020.06.011 |
0.567 |
|
| 2020 |
Stremitzer S, Vermeulen P, Graver S, Kockx M, Dirix L, Yang D, Zhang W, Stift J, Wrba F, Gruenberger T, Lenz HJ, Scherer SJ. Immune phenotype and histopathological growth pattern in patients with colorectal liver metastases. British Journal of Cancer. PMID 32205863 DOI: 10.1038/S41416-020-0812-Z |
0.339 |
|
| 2020 |
Rypens C, Marsan M, Van Berckelaer C, Billiet C, Melis K, Lopez SP, van Dam P, Devi GR, Finetti P, Ueno NT, Bertucci F, Dirix P, Neven P, Vermeulen P, Dirix L, et al. Inflammatory breast cancer cells are characterized by abrogated TGFβ1-dependent cell motility and SMAD3 activity. Breast Cancer Research and Treatment. PMID 32043194 DOI: 10.1007/S10549-020-05571-Z |
0.688 |
|
| 2020 |
Berckelaer CV, Rypens C, Laere SV, Marien K, Dam PV, Vermeulen PB, Colpaert C, Dirix LY, Kockx M, Dam PV. The spatial localization of CD163+ tumor-associated macrophages predicts prognosis and response to therapy in inflammatory breast cancer. Journal of Clinical Oncology. 38: 3086-3086. DOI: 10.1200/Jco.2020.38.15_Suppl.3086 |
0.457 |
|
| 2020 |
Berckelaer CV, Rypens C, Laere SV, Marien K, Dam Pv, Vermeulen P, Dirix L, Kockx M, Colpaert C, Dam Pv. Abstract P5-04-04: The spatial interactions between FOXP3+ Tregs, CD8+ cytotoxic T cells and tumor cells predict response to therapy and prognosis in inflammatory breast cancer Cancer Research. DOI: 10.1158/1538-7445.Sabcs19-P5-04-04 |
0.421 |
|
| 2020 |
Rypens C, Bertucci F, Viens P, Martens JW, Smid M, Schröder C, Ueno NT, Cristofanilli M, Dirix P, Vermeulen P, Dirix L, Laere SV. Abstract P3-03-03: Inflammatory breast cancer exhibits amplification and transcriptional activation of MYC in conjunction with NOTCH and TGFβ signaling Cancer Research. 80. DOI: 10.1158/1538-7445.Sabcs19-P3-03-03 |
0.479 |
|
| 2020 |
Vermeulen PB, Bohlok A, Leduc S, Richard F, Botzenhart L, Ignatiadis M, Aftimos P, Sotiriou C, Piccart M, Hendlisz A, Laere SV, Dirix LY, Noël J, Lucidi V, Biganzoli E, et al. Abstract P3-01-13: Association between the histopathological growth patterns (HGP) of liver metastases (LM) and survival after hepatic surgery in patients with oligometastatic breast cancer (BC) Cancer Research. 80. DOI: 10.1158/1538-7445.Sabcs19-P3-01-13 |
0.454 |
|
| 2020 |
Berckelaer CV, Rypens C, Vermeulen P, Laere SV, Dam PV, Colpaert C. Abstract P3-01-08: Infiltrating immune cells in the tumor emboli of inflammatory breast cancer Cancer Research. 80. DOI: 10.1158/1538-7445.Sabcs19-P3-01-08 |
0.465 |
|
| 2020 |
Peeters D, Buys A, Ledegen H, Moehlig K, Oeyen S, Rondas D, Beukelaer AD, Laere SV, Vervoort L, Vermeulen P, Ung C, Kockx M, Dirix L. Abstract OT3-18-02: A comparative study of two detection platforms of circulating tumour cells in patients with metastatic breast cancer Cancer Research. DOI: 10.1158/1538-7445.Sabcs19-Ot3-18-02 |
0.52 |
|
| 2020 |
Höppener D, Nierop P, Hof J, Sideras K, Zhou G, Jong Kd, Sprengers D, Kwekkeboom J, Vermeulen P, Grünhagen D, Verhoef C. Observed differences in the tumour microenvironment provide a potential explanation for the superior survival of patients with desmoplastic colorectal liver metastasis Ejso. 46. DOI: 10.1016/J.Ejso.2019.11.483 |
0.354 |
|
| 2020 |
Haas G, Oliveira TD, Wachter A, Menck K, Bohnenberger H, Edelmann M, Goldhardt T, Wiemann S, Beißbarth T, Homayounfar K, Vermeulen P, Ghadimi M, Bleckmann A, Conradi L. Molecular Characterization of Different Histopathological Growth Patterns in Colorectal Cancer Liver Metastases Ejso. 46. DOI: 10.1016/J.Ejso.2019.11.175 |
0.391 |
|
| 2019 |
Bertucci F, Rypens C, Finetti P, Guille A, Adelaïde J, Monneur A, Carbuccia N, Garnier S, Dirix P, Gonçalves A, Vermeulen P, Debeb BG, Wang X, Dirix L, Ueno NT, et al. NOTCH and DNA repair pathways are more frequently targeted by genomic alterations in inflammatory than in non-inflammatory breast cancers. Molecular Oncology. PMID 31854063 DOI: 10.1002/1878-0261.12621 |
0.621 |
|
| 2019 |
Nierop PMH, Höppener DJ, van der Stok EP, Galjart B, Buisman FE, Balachandran VP, Jarnagin WR, Kingham TP, Allen PJ, Shia J, Vermeulen PB, Groot Koerkamp B, Grünhagen DJ, Verhoef C, D'Angelica MI. Histopathological growth patterns and positive margins after resection of colorectal liver metastases. Hpb : the Official Journal of the International Hepato Pancreato Biliary Association. PMID 31735649 DOI: 10.1016/J.Hpb.2019.10.015 |
0.317 |
|
| 2019 |
Lugassy C, Kleinman HK, Vermeulen PB, Barnhill RL. Angiotropism, pericytic mimicry and extravascular migratory metastasis: an embryogenesis-derived program of tumor spread. Angiogenesis. 23: 27-41. PMID 31720876 DOI: 10.1007/S10456-019-09695-9 |
0.432 |
|
| 2019 |
Latacz E, Caspani E, Barnhill R, Lugassy C, Verhoef C, Grünhagen D, Van Laere S, Fernández Moro C, Gerling M, Dirix M, Dirix LY, Vermeulen PB. Pathological features of vessel co-option versus sprouting angiogenesis. Angiogenesis. PMID 31655928 DOI: 10.1007/S10456-019-09690-0 |
0.645 |
|
| 2019 |
Höppener DJ, Nierop PMH, Herpel E, Rahbari NN, Doukas M, Vermeulen PB, Grünhagen DJ, Verhoef C. Histopathological growth patterns of colorectal liver metastasis exhibit little heterogeneity and can be determined with a high diagnostic accuracy. Clinical & Experimental Metastasis. 36: 311-319. PMID 31134394 DOI: 10.1007/S10585-019-09975-0 |
0.353 |
|
| 2019 |
Nierop PMH, Galjart B, Höppener DJ, van der Stok EP, Coebergh van den Braak RRJ, Vermeulen PB, Grünhagen DJ, Verhoef C. Salvage treatment for recurrences after first resection of colorectal liver metastases: the impact of histopathological growth patterns. Clinical & Experimental Metastasis. 36: 109-118. PMID 30843120 DOI: 10.1007/S10585-019-09960-7 |
0.338 |
|
| 2019 |
Kuczynski EA, Vermeulen PB, Pezzella F, Kerbel RS, Reynolds AR. Vessel co-option in cancer. Nature Reviews. Clinical Oncology. PMID 30816337 DOI: 10.1038/S41571-019-0181-9 |
0.365 |
|
| 2019 |
Van Berckelaer C, Rypens C, van Dam P, Pouillon L, Parizel M, Schats KA, Kockx M, Tjalma WAA, Vermeulen P, van Laere S, Bertucci F, Colpaert C, Dirix L. Infiltrating stromal immune cells in inflammatory breast cancer are associated with an improved outcome and increased PD-L1 expression. Breast Cancer Research : Bcr. 21: 28. PMID 30777104 DOI: 10.1186/S13058-019-1108-1 |
0.673 |
|
| 2019 |
Nik-Zainal S, Davies H, Staaf J, Ramakrishna M, Glodzik D, Zou X, Martincorena I, Alexandrov LB, Martin S, Wedge DC, Van Loo P, Ju YS, Smid M, Brinkman AB, Morganella S, ... ... Vermeulen P, et al. Author Correction: Landscape of somatic mutations in 560 breast cancer whole-genome sequences. Nature. PMID 30659290 DOI: 10.1038/S41586-019-0883-2 |
0.728 |
|
| 2019 |
Galjart B, Nierop PMH, van der Stok EP, van den Braak RRJC, Höppener DJ, Daelemans S, Dirix LY, Verhoef C, Vermeulen PB, Grünhagen DJ. Angiogenic desmoplastic histopathological growth pattern as a prognostic marker of good outcome in patients with colorectal liver metastases. Angiogenesis. 22: 355-368. PMID 30637550 DOI: 10.1007/S10456-019-09661-5 |
0.38 |
|
| 2019 |
Bohlok A, Dezes R, Lucidi V, Bouazza F, Germanova D, Van Laethem JL, Hendlisz A, Demetter P, Larsimont D, Donckier V, Vermeulen PB. Histological growth pattern as a potential marker of oligometastatic disease in patients operated for colorectal liver metastases. Journal of Clinical Oncology. 37: e15093-e15093. DOI: 10.1200/Jco.2019.37.15_Suppl.E15093 |
0.374 |
|
| 2019 |
Bohlok A, Botzenhart L, Lucidi V, Noel JC, Demetter P, Larsimont D, Donckier V, Vermeulen PB. Histological growth pattern as a potential prognostic factor in patients operated for breast cancer liver metastases. Journal of Clinical Oncology. 37: e12576-e12576. DOI: 10.1200/Jco.2019.37.15_Suppl.E12576 |
0.436 |
|
| 2019 |
Vermeulen P, Dam Pv, Daelemans S, Latacz E, Joye I, Kockx M, Dirix P, Verhoef K, Grunhagen D, Huget P, Laere SV, Dirix L. Abstract PD9-08: Breast cancer liver metastases vascularize by vessel co-option, not angiogenesis, and have a desert immune phenotype: A histopathological and gene expression study Cancer Research. 79. DOI: 10.1158/1538-7445.Sabcs18-Pd9-08 |
0.537 |
|
| 2019 |
Berckelaer CV, Colpaert C, Rypens C, Marien K, Waumans Y, Kockx M, Vermeulen P, Dirix L, Laere SV, Dam PV. Abstract P4-06-08: The spatial localization of immune cells predicts prognosis and response to therapy in inflammatory breast cancer Cancer Research. DOI: 10.1158/1538-7445.Sabcs18-P4-06-08 |
0.423 |
|
| 2019 |
Laere SV, Finetti P, Rypens C, Billet C, Birnbaum D, Vermeulen P, Viens P, Dirix L, Bertucci F. Abstract P4-04-04: The mutational profile of inflammatory breast cancer reveals a higher mutational burden leading to MAPK activation and chromatin remodeling Cancer Research. DOI: 10.1158/1538-7445.Sabcs18-P4-04-04 |
0.388 |
|
| 2019 |
Mercier C, Billiet C, Strijbos M, Mooter TVd, Vandaele F, Joye I, Buys A, Rypens C, Oeyen S, Laere SJV, Vermeulen P, Dirix P. Adding ADT to PSMA-PET/CT-guided SBRT for oligometastatic prostate cancer improves distant progression-free survival Annals of Oncology. 30. DOI: 10.1093/Annonc/Mdz248.028 |
0.321 |
|
| 2019 |
Bohlok A, Botzenhart L, Lucidi V, Noël JC, Demetter P, Larsimont D, Donckier V, Vermeulen P. 374PPrognostic value of histological growth pattern in patients operated for breast cancer liver metastases Annals of Oncology. 30. DOI: 10.1093/Annonc/Mdz242.069 |
0.477 |
|
| 2019 |
Goethem AV, Rypens C, Rutten A, Mooter TVd, Erven K, Havenbergh TV, Prové A, Laere SJV, Vermeulen P, Dirix LY. Sensitivity and dynamic range of CellSearch based CSF DTC enumeration in patients with breast cancer related leptomeningeal metastases (LM). Annals of Oncology. 30. DOI: 10.1093/Annonc/Mdz100.038 |
0.465 |
|
| 2019 |
Berckelaer CV, Colpaert CG, Rypens C, Marien K, Kockx M, Waumans Y, Vermeulen P, Dirix LY, Laere SJV, Dam PV. The spatial relations among immune cells are prognostic in inflammatory breast cancer Annals of Oncology. 30. DOI: 10.1093/Annonc/Mdz095.030 |
0.449 |
|
| 2019 |
Machiels M, Weytjens R, Erven K, Westerhoff J, Amrouch S, Bosiers J, Verkinderen L, Hauspy J, Van Dam P, Dirix P, Vos M, Huget P, Dirix L, Meijnders P, Van Laere S, ... Vermeulen P, et al. PO-0765 Oncological and cosmetic outcome after IOERT as a boost in a large cohort of breast cancer patients. Radiotherapy and Oncology. 133: S393-S394. DOI: 10.1016/S0167-8140(19)31185-5 |
0.457 |
|
| 2019 |
Galjart B, Stok EPvd, Braak RRCvd, Nierop PM, Rothbarth J, Grünhagen DJ, Vermeulen PB, Verhoef C. The effect of histopathological growth patterns on recurrence after resection of colorectal liver metastasis. Hpb. 21. DOI: 10.1016/J.Hpb.2019.10.1226 |
0.316 |
|
| 2019 |
Nierop M, Galjart B, Höppener D, van der Stok E, Coebergh van den Braak R, Daelemans S, Vermeulen P, Grünhagen D, Verhoef C. Histopathological growth patterns impact the efficacy of treatment for recurrent disease in patients with resected colorectal liver metastases European Journal of Surgical Oncology. 45: e132. DOI: 10.1016/J.Ejso.2018.10.452 |
0.319 |
|
| 2019 |
Nierop M, Höppener D, Stok Evd, Boris G, Buisman F, Balachandran V, deMatteo R, Jarnagin W, Kingham P, Allen P, Shia J, Vermeulen P, Koerkamp BG, Grünhagen D, Verhoef C, et al. Histopathological growth patterns and positive margins after resection of colorectal liver metastases Ejso. 45. DOI: 10.1016/J.Ejso.2018.10.451 |
0.306 |
|
| 2019 |
Buisman F, Stok Evd, Galjart B, Vermeulen P, Allen P, Balanchandran V, Jarnagin W, Kingham P, Grünhagen D, Koerkamp BG, D'Angelica M, Verhoef C. Histopathological growth patterns as a guide for adjuvant systemic chemotherapy in patients with resected colorectal liver metastases Ejso. 45. DOI: 10.1016/J.Ejso.2018.10.069 |
0.335 |
|
| 2018 |
Mercier C, Dirix P, Meijnders P, Vermeulen P, Van Laere S, Debois H, Huget P, Verellen D. A phase I dose-escalation trial of stereotactic ablative body radiotherapy for non-spine bone and lymph node metastases (DESTROY-trial). Radiation Oncology (London, England). 13: 152. PMID 30126440 DOI: 10.1186/S13014-018-1096-9 |
0.583 |
|
| 2018 |
Steenbrugge J, Breyne K, Demeyere K, De Wever O, Sanders NN, Van Den Broeck W, Colpaert C, Vermeulen P, Van Laere S, Meyer E. Anti-inflammatory signaling by mammary tumor cells mediates prometastatic macrophage polarization in an innovative intraductal mouse model for triple-negative breast cancer. Journal of Experimental & Clinical Cancer Research : Cr. 37: 191. PMID 30111338 DOI: 10.1186/S13046-018-0860-X |
0.704 |
|
| 2018 |
Donnem T, Reynolds AR, Kuczynski EA, Gatter K, Vermeulen PB, Kerbel RS, Harris AL, Pezzella F. Non-angiogenic tumours and their influence on cancer biology. Nature Reviews. Cancer. PMID 29520090 DOI: 10.1038/Nrc.2018.14 |
0.366 |
|
| 2018 |
van Dam PJ, Daelemans S, Ross E, Waumans Y, Laere SV, Latacz E, Steen RV, Pooter C, Kockx M, Dirix L, Vermeulen PB. Histopathological growth patterns as a candidate biomarker for immunomodulatory therapy. Seminars in Cancer Biology. PMID 29355613 DOI: 10.1016/J.Semcancer.2018.01.009 |
0.396 |
|
| 2018 |
Evans MK, Brown MC, Geradts J, Bao X, Robinson TJ, Jolly MK, Vermeulen P, Palmer GM, Gromeier M, Levine H, Morse MA, Van Laere S, Devi GR. XIAP regulation by MNK links MAPK and NFκB signaling to determine an aggressive breast cancer phenotype. Cancer Research. PMID 29351901 DOI: 10.1158/0008-5472.Can-17-1667 |
0.683 |
|
| 2018 |
Höppener D, Nierop P, Vermeulen P, Grünhagen D, Verhoef C. Intra-metastases and intra-patient single time-frame histopathological growth patterns concordance of resected colorectal liver metastases Hpb. 20: S307. DOI: 10.1016/J.Hpb.2018.06.315 |
0.335 |
|
| 2018 |
Höppener D, Nierop P, Vermeulen P, Grünhagen D, Verhoef C. The relationship between circulating tumour cells and the histopathological growth pattern of resectable colorectal liver metastases Hpb. 20: S354-S355. DOI: 10.1016/J.Hpb.2018.06.2590 |
0.333 |
|
| 2018 |
Nierop P, Galjart B, van der Stok E, Coebergh van den Braak R, Daelemans S, Dirix L, Verhoef C, Vermeulen P, Grünhagen D. The desmoplastic growth pattern predicts improved survival after resection of colorectal liver metastases Hpb. 20: S225. DOI: 10.1016/J.Hpb.2018.06.118 |
0.305 |
|
| 2017 |
van Dam PJ, van der Stok EP, Teuwen LA, Van den Eynden GG, Illemann M, Frentzas S, Majeed AW, Eefsen RL, Coebergh van den Braak RRJ, Lazaris A, Fernandez MC, Galjart B, Laerum OD, Rayes R, Grünhagen DJ, ... ... Vermeulen PB, et al. International consensus guidelines for scoring the histopathological growth patterns of liver metastasis. British Journal of Cancer. PMID 28982110 DOI: 10.1038/Bjc.2017.334 |
0.715 |
|
| 2017 |
Joglekar-Javadekar M, Van Laere S, Bourne M, Moalwi M, Finetti P, Vermeulen PB, Birnbaum D, Dirix LY, Ueno N, Carter M, Rains J, Ramachandran A, Bertucci F, van Golen KL. Characterization and Targeting of Platelet-Derived Growth Factor Receptor alpha (PDGFRA) in Inflammatory Breast Cancer (IBC). Neoplasia (New York, N.Y.). 19: 564-573. PMID 28609680 DOI: 10.1016/J.Neo.2017.03.002 |
0.702 |
|
| 2017 |
Arora J, Sauer SJ, Tarpley M, Vermeulen P, Rypens C, Van Laere S, Williams KP, Devi GR, Dewhirst MW. Inflammatory breast cancer tumor emboli express high levels of anti-apoptotic proteins: use of a quantitative high content and high-throughput 3D IBC spheroid assay to identify targeting strategies. Oncotarget. 8: 25848-25863. PMID 28460441 DOI: 10.18632/Oncotarget.15667 |
0.67 |
|
| 2017 |
Brouwer A, Verhoest F, Vermeulen P, Rutten A, Prové A, Laere SV, Peeters M, Dirix L. Abstract P3-05-10: Evaluation of HER2 expression and amplification on CTCs using DEPArray analysis and sorting followed by FISH Cancer Research. 77. DOI: 10.1158/1538-7445.Sabcs16-P3-05-10 |
0.479 |
|
| 2017 |
Palmieri V, Lazaris A, Alamri H, Amri A, Ibrahim N, Zoroquiain P, Vermeulen P, Metrakos P. Abstract 2834: Metastatic colorectal cancer: characterization of distinct histological growth patterns which demonstrate different response to current treatment regimes Cancer Research. 77: 2834-2834. DOI: 10.1158/1538-7445.Am2017-2834 |
0.381 |
|
| 2017 |
Galjart B, Van der Stok E, Coebergh van den Braak R, Nierop P, Grünhagen D, Vermeulen P, Verhoef C. Histopathological growth patterns: A novel prognostic biomarker in patients with resected colorectal liver metastases European Journal of Cancer. 72: S66-S67. DOI: 10.1016/S0959-8049(17)30297-6 |
0.344 |
|
| 2017 |
Simoneau E, Vermeulen P, Eynden GVd, Reynolds A, Petrillo S, Valenti D, Metrakos P. The histological growth patterns of colorectal cancer liver metastasis are associated with disease progression post portal vein embolization Hpb. 19. DOI: 10.1016/J.Hpb.2017.02.058 |
0.393 |
|
| 2016 |
Frentzas S, Simoneau E, Bridgeman VL, Vermeulen PB, Foo S, Kostaras E, Nathan MR, Wotherspoon A, Gao ZH, Shi Y, Van den Eynden G, Daley F, Peckitt C, Tan X, Salman A, et al. Vessel co-option mediates resistance to anti-angiogenic therapy in liver metastases. Nature Medicine. PMID 27748747 DOI: 10.1038/Nm.4197 |
0.764 |
|
| 2016 |
Steenbrugge J, Breyne K, Denies S, Dekimpe M, Demeyere K, De Wever O, Vermeulen P, Van Laere S, Sanders NN, Meyer E. Comparison of the Adipose and Luminal Mammary Gland Compartment as Orthotopic Inoculation Sites in a 4T1-Based Immunocompetent Preclinical Model for Triple-Negative Breast Cancer. Journal of Mammary Gland Biology and Neoplasia. PMID 27714576 DOI: 10.1007/S10911-016-9362-7 |
0.636 |
|
| 2016 |
van der Stok EP, Smid M, Sieuwerts AM, Vermeulen PB, Sleijfer S, Ayez N, Grünhagen DJ, Martens JW, Verhoef C. mRNA expression profiles of colorectal liver metastases as a novel biomarker for early recurrence after partial hepatectomy. Molecular Oncology. 10: 1542-1550. PMID 27692894 DOI: 10.1016/J.Molonc.2016.09.002 |
0.336 |
|
| 2016 |
Marien KM, Croons V, Waumans Y, Sluydts E, De Schepper S, Andries L, Waelput W, Fransen E, Vermeulen PB, Kockx MM, De Meyer GR. Development and Validation of a Histological Method to Measure Microvessel Density in Whole-Slide Images of Cancer Tissue. Plos One. 11: e0161496. PMID 27583442 DOI: 10.1371/Journal.Pone.0161496 |
0.354 |
|
| 2016 |
Van Laere S, Dirix L, Vermeulen P. Molecular profiles to biology and pathways: a systems biology approach. Chinese Journal of Cancer. 35: 53. PMID 27311441 DOI: 10.1186/S40880-016-0112-4 |
0.567 |
|
| 2016 |
Nik-Zainal S, Davies H, Staaf J, Ramakrishna M, Glodzik D, Zou X, Martincorena I, Alexandrov LB, Martin S, Wedge DC, Van Loo P, Ju YS, Smid M, Brinkman AB, Morganella S, ... ... Vermeulen P, et al. Landscape of somatic mutations in 560 breast cancer whole-genome sequences. Nature. PMID 27135926 DOI: 10.1038/Nature17676 |
0.729 |
|
| 2016 |
Kuczynski EA, Yin M, Bar-Zion A, Lee CR, Butz H, Man S, Daley F, Vermeulen PB, Yousef GM, Foster FS, Reynolds AR, Kerbel RS. Co-option of Liver Vessels and Not Sprouting Angiogenesis Drives Acquired Sorafenib Resistance in Hepatocellular Carcinoma. Journal of the National Cancer Institute. 108. PMID 27059374 DOI: 10.1093/Jnci/Djw030 |
0.325 |
|
| 2016 |
Pastushenko I, Van den Eynden GG, Vicente-Arregui S, Prieto-Torres L, Alvarez-Alegret R, Querol I, Dirix LY, Carapeto FJ, Vermeulen PB, Van Laere SJ. Increased Angiogenesis and Lymphangiogenesis in Metastatic Sentinel Lymph Nodes Is Associated With Nonsentinel Lymph Node Involvement and Distant Metastasis in Patients With Melanoma. The American Journal of Dermatopathology. PMID 26909582 DOI: 10.1097/Dad.0000000000000488 |
0.727 |
|
| 2016 |
De Laere B, JE Peeters D, Brouwer A, Salgado R, A van Dam P, Rutten A, den Eynden GV, Denkert C, Teuwen L, Vermeulen PB, J Van Laere S, Y Dirix L. Patients with metastatic hormone receptor-positive breast cancer express PIK3CA oncogene mutational heterogeneity in circulating tumor cells Journal of Translational Science. 2. DOI: 10.15761/JTS.1000156 |
0.381 |
|
| 2016 |
Rypens C, Marsan M, Neven P, Vermeulen PB, Lardon F, Peeters M, Dirix L, Vandebroek J, Van Laere SJ. Patterns of canonical and non-canonical TGFβ signaling in inflammatory breast cancer cells on cancer cell motility. Journal of Clinical Oncology. 34: e23008-e23008. DOI: 10.1200/Jco.2016.34.15_Suppl.E23008 |
0.502 |
|
| 2016 |
Kaufman P, Arias-Pulido H, Colpaert C, Chaher N, Qualls C, Marotti J, Vermeulen P, Dirix L, Laere Sv, Kuppusamy P. Abstract P5-08-13: Tumor infiltrating lymphocytes and pathological response are prognostic biomarkers in inflammatory and non-inflammatory breast cancer Cancer Research. 76. DOI: 10.1158/1538-7445.Sabcs15-P5-08-13 |
0.529 |
|
| 2016 |
Brouwer A, Wiel Mvd, Peeters B, Dam Pv, Vermeulen P, Peeters M, Laere SV, Peeters D, Dirix L. Abstract P3-04-01: Manual and digital detection of HER2 status of 2721 circulating tumour cells in patients with metastatic breast cancer Cancer Research. 76. DOI: 10.1158/1538-7445.Sabcs15-P3-04-01 |
0.483 |
|
| 2016 |
Evans MK, Geradts J, Edwards C, Price A, Arora AJ, Aldrich AJ, Ramirez A, Robinson TJ, Vermeulen PB, Laere Sv, Devi GR. Abstract LB-015: XIAP induction by the MAPK-eIF4G1 pathway drives NFκB activation in inflammatory breast cancer growth and therapeutic resistance Cancer Research. 76. DOI: 10.1158/1538-7445.Am2016-Lb-015 |
0.482 |
|
| 2016 |
Nathan MR, Kostaras L, Bridgeman V, Foo S, Vermeulen P, Reynolds A. Abstract 4105: Dissecting the mechanisms of hepatocyte replacement in breast cancer liver metastases Cancer Research. 76: 4105-4105. DOI: 10.1158/1538-7445.Am2016-4105 |
0.508 |
|
| 2016 |
Lazaris A, Amri A, Zoroquiain P, Petrillo SK, Mattar R, Gao Z, Vermeulen P, Metrakos P. Abstract 1695: Vascularization of colorectal cancer liver metastasis: correlation with growth patterns Cancer Research. 76: 1695-1695. DOI: 10.1158/1538-7445.Am2016-1695 |
0.468 |
|
| 2015 |
Eefsen RL, Engelholm L, Alpizar-Alpizar W, Van den Eynden GG, Vermeulen PB, Christensen IJ, Laerum OD, Rolff HC, Høyer-Hansen G, Vainer B, Osterlind K, Illemann M. Inflammation and uPAR-Expression in Colorectal Liver Metastases in Relation to Growth Pattern and Neo-adjuvant Therapy. Cancer Microenvironment : Official Journal of the International Cancer Microenvironment Society. 8: 93-100. PMID 26268716 DOI: 10.1007/S12307-015-0172-Z |
0.648 |
|
| 2015 |
Pastushenko I, Vermeulen PB, Vicente-Arregui S, Van den Eynden GG, Alvarez-Alegret R, Querol I, Rutten A, Carapeto FJ, Dirix LY, Van Laere S. Peritumoral D2-40 Chalkley score independently predicts metastases and survival in patients with cutaneous malignant melanoma. Journal of Cutaneous Pathology. 42: 699-711. PMID 26264662 DOI: 10.1111/Cup.12571 |
0.729 |
|
| 2015 |
van Schooneveld E, Wildiers H, Vergote I, Vermeulen PB, Dirix LY, Van Laere SJ. Dysregulation of microRNAs in breast cancer and their potential role as prognostic and predictive biomarkers in patient management. Breast Cancer Research : Bcr. 17: 21. PMID 25849621 DOI: 10.1186/S13058-015-0526-Y |
0.627 |
|
| 2015 |
Eefsen RL, Vermeulen PB, Christensen IJ, Laerum OD, Mogensen MB, Rolff HC, Van den Eynden GG, Høyer-Hansen G, Osterlind K, Vainer B, Illemann M. Growth pattern of colorectal liver metastasis as a marker of recurrence risk. Clinical & Experimental Metastasis. 32: 369-81. PMID 25822899 DOI: 10.1007/S10585-015-9715-4 |
0.65 |
|
| 2015 |
Jansen MP, Sas L, Sieuwerts AM, Van Cauwenberghe C, Ramirez-Ardila D, Look M, Ruigrok-Ritstier K, Finetti P, Bertucci F, Timmermans MM, van Deurzen CH, Martens JW, Simon I, Roepman P, Linn SC, ... ... Vermeulen PB, et al. Decreased expression of ABAT and STC2 hallmarks ER-positive inflammatory breast cancer and endocrine therapy resistance in advanced disease. Molecular Oncology. 9: 1218-33. PMID 25771305 DOI: 10.1016/J.Molonc.2015.02.006 |
0.68 |
|
| 2015 |
Pastushenko I, Vicente-Arregui S, Van den Eynden GG, Gracia-Cazaña T, Carapeto FJ, Alvarez-Alegret R, Dirix LY, Vermeulen PB, Van Laere S. Melanomas arising on skin with chronic sun-induced damage exhibit low degree of angiogenesis and lymphangiogenesis. The American Journal of Dermatopathology. 37: 451-4. PMID 25747811 DOI: 10.1097/Dad.0000000000000265 |
0.713 |
|
| 2015 |
Peeters DJ, Brouwer A, Van den Eynden GG, Rutten A, Onstenk W, Sieuwerts AM, Van Laere SJ, Huget P, Pauwels P, Peeters M, Vermeulen PB, Dirix LY. Circulating tumour cells and lung microvascular tumour cell retention in patients with metastatic breast and cervical cancer. Cancer Letters. 356: 872-9. PMID 25449778 DOI: 10.1016/J.Canlet.2014.10.039 |
0.793 |
|
| 2015 |
De Laere B, Peeters DJE, Salgado R, Vermeulen PB, van Dam PA, Van Laere SJ, Dirix LY. Exploring the intra-patient PIK3CA mutational heterogeneity of circulating tumour cells by massive parallel sequencing in patients with metastatic hormone receptor-positive breast cancer. Journal of Clinical Oncology. 33: 11030-11030. DOI: 10.1200/Jco.2015.33.15_Suppl.11030 |
0.445 |
|
| 2015 |
Evans MK, Sauer SJ, Aldrich AJ, Geradts J, Vermeulen P, Dirix L, Laere SV, Devi GR. Abstract P6-14-05: A novel link between anti-apoptotic signaling, NFκB, and SMAD7 in IBC pathobiology Cancer Research. 75. DOI: 10.1158/1538-7445.Sabcs14-P6-14-05 |
0.451 |
|
| 2015 |
Colpaert C, Marsan M, Vermeulen P, Dirix L, Laere SV. Abstract P4-04-20: Tumor infiltrating lymphocytes in inflammatory breast cancer Cancer Research. 75. DOI: 10.1158/1538-7445.Sabcs14-P4-04-20 |
0.52 |
|
| 2015 |
Peeters DJ, Beeck KOD, Brouwer A, Vandeweyer G, Pauwels P, Peeters M, Vermeulen PB, Dam PAv, Laere SJV, Camp GV, Dirix LY. Abstract P4-01-14: Whole exome sequencing of circulating and disseminated tumour cells in patients with metastatic breast cancer Cancer Research. 75. DOI: 10.1158/1538-7445.Sabcs14-P4-01-14 |
0.451 |
|
| 2015 |
Colpaert C, Marsan M, Vermeulen P, Dirix L, Laere SV. Abstract P3-06-39: Anaplastic lymphoma kinase (ALK) protein overexpression is not a feature of inflammatory breast cancer Cancer Research. 75. DOI: 10.1158/1538-7445.Sabcs14-P3-06-39 |
0.45 |
|
| 2015 |
Marsan M, Eynden GVd, Neven P, Vergote I, Vermeulen P, Dirix L, Laere SV. Abstract P1-07-09: SMAD nuclear staining patterns in inflammatory breast cancer suggest non-canonical TGFβ-signalling establishing collective, sheet-like invasion SMAD nuclear staining patterns in inflammatory breast cancer suggest non-canonical TGFβ-signalling es Cancer Research. 75. DOI: 10.1158/1538-7445.Sabcs14-P1-07-09 |
0.517 |
|
| 2015 |
Colpaert CG, Marsan M, Eynden GVd, Vermeulen P, Dirix LY, Laere SV. 76PTumour infiltrating lymphocytes in inflammatory breast cancer Annals of Oncology. 26. DOI: 10.1093/Annonc/Mdv118.02 |
0.474 |
|
| 2015 |
De Laere B, Peeters D, Salgado R, Vermeulen P, van Dam P, Dirix L, Van Laere S. Exploring the intra-patient PIK3CA mutational heterogeneity of circulating tumour cells by massive parallel sequencing in patients with metastatic hormone receptor-positive breast cancer Annals of Oncology. 26: iii15. DOI: 10.1093/ANNONC/MDV117.03 |
0.349 |
|
| 2015 |
Peeters D, Brouwer A, Op de Beeck K, Van de Weyer G, Pauwels P, Peeters M, Vermeulen P, Van Laere S, Van Camp G, Dirix L. Whole exome sequencing of circulating and disseminated tumour cells in patients with metastatic breast cancer Annals of Oncology. 26: iii10. DOI: 10.1093/Annonc/Mdv116.04 |
0.503 |
|
| 2014 |
Van den Eynden GG, Bird NC, Dirix LY, Eefsen RL, Gao ZH, Høyer-Hansen G, Illemann M, Majeed AW, Metrakos P, Reynolds AR, Vainer B, van Dam PJ, Van Laere SJ, Vermeulen PB, Vidal-Vanaclocha F, et al. Tumor stromal phenotypes define VEGF sensitivity--letter. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 20: 5140. PMID 25274379 DOI: 10.1158/1078-0432.Ccr-14-0158 |
0.697 |
|
| 2014 |
Bertucci F, Finetti P, Vermeulen P, Van Dam P, Dirix L, Birnbaum D, Viens P, Van Laere S. Genomic profiling of inflammatory breast cancer: a review. Breast (Edinburgh, Scotland). 23: 538-45. PMID 24998451 DOI: 10.1016/J.Breast.2014.06.008 |
0.677 |
|
| 2014 |
Pastushenko I, Gracia-Cazaña T, Vicente-Arregui S, Van den Eynden GG, Ara M, Vermeulen PB, Carapeto FJ, Van Laere SJ. Squamous cell carcinomas of the skin explore angiogenesis-independent mechanisms of tumour vascularization. Journal of Skin Cancer. 2014: 651501. PMID 24891955 DOI: 10.1155/2014/651501 |
0.716 |
|
| 2014 |
Pastushenko I, Vermeulen PB, Van den Eynden GG, Rutten A, Carapeto FJ, Dirix LY, Van Laere S. Mechanisms of tumour vascularization in cutaneous malignant melanoma: clinical implications. The British Journal of Dermatology. 171: 220-33. PMID 24641095 DOI: 10.1111/Bjd.12973 |
0.748 |
|
| 2014 |
Marsan M, Van den Eynden G, Limame R, Neven P, Hauspy J, Van Dam PA, Vergote I, Dirix LY, Vermeulen PB, Van Laere SJ. A core invasiveness gene signature reflects epithelial-to-mesenchymal transition but not metastatic potential in breast cancer cell lines and tissue samples. Plos One. 9: e89262. PMID 24586640 DOI: 10.1371/Journal.Pone.0089262 |
0.798 |
|
| 2014 |
Peeters DJ, van Dam PJ, Van den Eynden GG, Rutten A, Wuyts H, Pouillon L, Peeters M, Pauwels P, Van Laere SJ, van Dam PA, Vermeulen PB, Dirix LY. Detection and prognostic significance of circulating tumour cells in patients with metastatic breast cancer according to immunohistochemical subtypes. British Journal of Cancer. 110: 375-83. PMID 24366294 DOI: 10.1038/Bjc.2013.743 |
0.807 |
|
| 2014 |
Van den Eynden GG, van Dam PJ, Stroobants S, Dirix L, Vermeulen P. Histopathological evaluation of resected colorectal cancer liver metastases: what should be done? Histopathology. 64: 315-6. PMID 24330151 DOI: 10.1111/his.12259 |
0.618 |
|
| 2014 |
Bertucci F, Ueno NT, Finetti P, Vermeulen P, Lucci A, Robertson FM, Marsan M, Iwamoto T, Krishnamurthy S, Masuda H, Van Dam P, Woodward WA, Cristofanilli M, Reuben JM, Dirix L, et al. Gene expression profiles of inflammatory breast cancer: correlation with response to neoadjuvant chemotherapy and metastasis-free survival. Annals of Oncology : Official Journal of the European Society For Medical Oncology / Esmo. 25: 358-65. PMID 24299959 DOI: 10.1093/Annonc/Mdt496 |
0.684 |
|
| 2014 |
Pastushenko I, Vermeulen PB, Carapeto FJ, Van den Eynden G, Rutten A, Ara M, Dirix LY, Van Laere S. Blood microvessel density, lymphatic microvessel density and lymphatic invasion in predicting melanoma metastases: systematic review and meta-analysis. The British Journal of Dermatology. 170: 66-77. PMID 24134623 DOI: 10.1111/Bjd.12688 |
0.734 |
|
| 2014 |
Sas L, Vermeulen PB, van Dam P, Dirix LY, Lardon F, Van Laere SJ. Contribution of ER and NF-κB to endocrine resistance in inflammatory breast cancer Breast Cancer Management. 3: 53-61. DOI: 10.2217/Bmt.13.72 |
0.495 |
|
| 2014 |
Frentzas S, Thompson VL, Vermeulen PB, Foo S, Brown G, Cunningham D, Reynolds AR. Abstract 2997: Vessel co-option in colorectal cancer liver metastases mediates resistance to VEGF-targeted therapy Cancer Research. 74: 2997-2997. DOI: 10.1158/1538-7445.Am2014-2997 |
0.434 |
|
| 2014 |
Sucaet Y, Waelput W, Vermeulen P, Van den Eynden G. Using a Novel Whole Slide Imaging Software Platform for an International Multicenter Validation Study to Assess the Histological Growth Pattern of Liver Metastases Analytical Cellular Pathology. 2014: 1-2. DOI: 10.1155/2014/812391 |
0.652 |
|
| 2014 |
Thompson V, Frentzas S, Vermeulen P, Foo S, Eltahir Z, Brown G, Cunningham D, Reynolds A. 32: Proffered Paper: Vessel co-option in colorectal cancer liver metastases mediates resistance to conventional anti-angiogenic therapy European Journal of Cancer. 50: S9. DOI: 10.1016/S0959-8049(14)50032-9 |
0.367 |
|
| 2013 |
Woodward WA, Krishnamurthy S, Yamauchi H, El-Zein R, Ogura D, Kitadai E, Niwa SI, Cristofanilli M, Vermeulen P, Dirix L, Viens P, Van Laere S, Bertucci F, Reuben JM, Ueno NT. Genomic and expression analysis of microdissected inflammatory breast cancer Breast Cancer Research and Treatment. 138: 761-772. PMID 23568481 DOI: 10.1007/S10549-013-2501-6 |
0.389 |
|
| 2013 |
Van den Eynden GG, Majeed AW, Illemann M, Vermeulen PB, Bird NC, Høyer-Hansen G, Eefsen RL, Reynolds AR, Brodt P. The multifaceted role of the microenvironment in liver metastasis: biology and clinical implications. Cancer Research. 73: 2031-43. PMID 23536564 DOI: 10.1158/0008-5472.Can-12-3931 |
0.668 |
|
| 2013 |
van Dam PA, Verheyden G, Sugihara A, Trinh XB, Van Der Mussele H, Wuyts H, Verkinderen L, Hauspy J, Vermeulen P, Dirix L. A dynamic clinical pathway for the treatment of patients with early breast cancer is a tool for better cancer care: implementation and prospective analysis between 2002-2010. World Journal of Surgical Oncology. 11: 70. PMID 23497270 DOI: 10.1186/1477-7819-11-70 |
0.392 |
|
| 2013 |
Peeters DJ, De Laere B, Van den Eynden GG, Van Laere SJ, Rothé F, Ignatiadis M, Sieuwerts AM, Lambrechts D, Rutten A, van Dam PA, Pauwels P, Peeters M, Vermeulen PB, Dirix LY. Semiautomated isolation and molecular characterisation of single or highly purified tumour cells from CellSearch enriched blood samples using dielectrophoretic cell sorting. British Journal of Cancer. 108: 1358-67. PMID 23470469 DOI: 10.1038/Bjc.2013.92 |
0.716 |
|
| 2013 |
Van Laere SJ, Ueno NT, Finetti P, Vermeulen P, Lucci A, Robertson FM, Marsan M, Iwamoto T, Krishnamurthy S, Masuda H, van Dam P, Woodward WA, Viens P, Cristofanilli M, Birnbaum D, et al. Uncovering the molecular secrets of inflammatory breast cancer biology: an integrated analysis of three distinct affymetrix gene expression datasets. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 19: 4685-96. PMID 23396049 DOI: 10.1158/1078-0432.Ccr-12-2549 |
0.694 |
|
| 2013 |
Lehman HL, Dashner EJ, Lucey M, Vermeulen P, Dirix L, Van Laere S, van Golen KL. Modeling and characterization of inflammatory breast cancer emboli grown in vitro. International Journal of Cancer. 132: 2283-94. PMID 23129218 DOI: 10.1002/Ijc.27928 |
0.694 |
|
| 2013 |
Eefsen RL, Eynden GG, Alpizar-Alpizar W, Høyer-Hansen G, Christensen IJ, Engelholm L, Lærum OD, Vermeulen PB, Østerlind K, Vainer B, Illemann M. Abstract B21: Macrophages and T cell infiltration in colorectal liver metastases according to growth pattern Cancer Research. 73. DOI: 10.1158/1538-7445.Tim2013-B21 |
0.371 |
|
| 2013 |
Sas L, Dam PV, Dirix L, Vermeulen P, Lardon F, Laere SV. Abstract 99: Identification of genes involved in NFκB driven resistance to endocrine treatment in breast cancer. Endocrinology. 73: 99-99. DOI: 10.1158/1538-7445.Am2013-99 |
0.449 |
|
| 2013 |
Joglekar M, Laere SV, Vermeulen P, Dirix L, Carter M, Rhamchandran A, Golen Kv. Abstract P6-12-15: Preclinical testing of a novel platelet derived growth factor receptor alpha (PDGFRa) inhibitor in inflammatory breast cancer Cancer Research. 73. DOI: 10.1158/0008-5472.Sabcs13-P6-12-15 |
0.484 |
|
| 2013 |
Sas L, Dirix L, Vermeulen P, Dam PV, Lardon F, Laere SV. Abstract P5-09-04: The effect of nuclear factor kappa B activation on cell proliferation of estrogen receptor positive breast cancer cell lines with different HER2-status Cancer Research. 73. DOI: 10.1158/0008-5472.Sabcs13-P5-09-04 |
0.435 |
|
| 2013 |
Laere SV, Marsan M, Vermeulen P, Viens P, Barsky S, Cristofanilli M, Dirix L, Bertucci F, Robertson F. Abstract P2-05-04: Comparative expression profiling of patient samples and preclinical models of inflammatory breast cancer reveals gene signatures of epithelial plasticity and suppression of TGFb signaling Cancer Research. 73. DOI: 10.1158/0008-5472.Sabcs13-P2-05-04 |
0.456 |
|
| 2013 |
Laere BD, Peeters D, Schooneveld Ev, Salgado R, Vermeulen P, Dirix L, Laere SV. Abstract P1-04-04: Towards methodology of detecting PIK3CA mutations on single cell level by massive parallel sequencing Cancer Research. 73. DOI: 10.1158/0008-5472.Sabcs13-P1-04-04 |
0.426 |
|
| 2013 |
Peeters D, Kumar P, Aa NVd, Rothé F, Theunis K, Beeck KOd, Laere SV, Vermeulen P, Dam Pv, Vincent D, Desmedt C, Sotiriou C, Dirix L, Ignatiadis M, Voet T. Abstract P1-04-03: Genome-wide analysis of copy number variations and mutation profiles of single circulating tumour cells using massively parallel paired-end sequencing Cancer Research. 73. DOI: 10.1158/0008-5472.Sabcs13-P1-04-03 |
0.377 |
|
| 2012 |
Sas L, Lardon F, Vermeulen PB, Hauspy J, Van Dam P, Pauwels P, Dirix LY, Van Laere SJ. The interaction between ER and NFκB in resistance to endocrine therapy. Breast Cancer Research : Bcr. 14: 212. PMID 22963717 DOI: 10.1186/Bcr3196 |
0.651 |
|
| 2012 |
Eefsen RL, Van den Eynden GG, Høyer-Hansen G, Brodt P, Laerum OD, Vermeulen PB, Christensen IJ, Wettergren A, Federspiel B, Willemoe GL, Vainer B, Osterlind K, Illemann M. Histopathological growth pattern, proteolysis and angiogenesis in chemonaive patients resected for multiple colorectal liver metastases. Journal of Oncology. 2012: 907971. PMID 22919385 DOI: 10.1155/2012/907971 |
0.633 |
|
| 2012 |
Lehman HL, Van Laere SJ, van Golen CM, Vermeulen PB, Dirix LY, van Golen KL. Regulation of inflammatory breast cancer cell invasion through Akt1/PKBα phosphorylation of RhoC GTPase. Molecular Cancer Research : McR. 10: 1306-18. PMID 22896661 DOI: 10.1158/1541-7786.Mcr-12-0173 |
0.705 |
|
| 2012 |
Van den Eynden GG, Bird NC, Majeed AW, Van Laere S, Dirix LY, Vermeulen PB. The histological growth pattern of colorectal cancer liver metastases has prognostic value. Clinical & Experimental Metastasis. 29: 541-9. PMID 22476470 DOI: 10.1007/S10585-012-9469-1 |
0.736 |
|
| 2012 |
Dirix LY, Vermeulen PB. Inflammatory HER2-positive breast cancer. The Lancet. Oncology. 13: 324-6. PMID 22377127 DOI: 10.1016/S1470-2045(12)70081-5 |
0.471 |
|
| 2012 |
van Schooneveld E, Wouters MC, Van der Auwera I, Peeters DJ, Wildiers H, Van Dam PA, Vergote I, Vermeulen PB, Dirix LY, Van Laere SJ. Expression profiling of cancerous and normal breast tissues identifies microRNAs that are differentially expressed in serum from patients with (metastatic) breast cancer and healthy volunteers. Breast Cancer Research : Bcr. 14: R34. PMID 22353773 DOI: 10.1186/Bcr3127 |
0.655 |
|
| 2012 |
Trinh XB, Sas L, Van Laere SJ, Prové A, Deleu I, Rasschaert M, Van de Velde H, Vinken P, Vermeulen PB, Van Dam PA, Wojtasik A, De Mesmaeker P, Tjalma WA, Dirix LY. A phase II study of the combination of endocrine treatment and bortezomib in patients with endocrine-resistant metastatic breast cancer. Oncology Reports. 27: 657-63. PMID 22134540 DOI: 10.1158/0008-5472.Sabcs-09-4099 |
0.674 |
|
| 2012 |
Laere SJV, Jansen MP, Sas L, Sieuwerts A, Vermeulen PB, Berns EM, Dirix LY. Abstract 684: Identification of biomarker genes associated with endocrine therapy responsiveness in patients with estrogen receptor positive IBC and nIBC Cancer Research. 72: 684-684. DOI: 10.1158/1538-7445.Am2012-684 |
0.44 |
|
| 2012 |
Limame R, Laere SV, Beeck KOD, Camp GV, Vermeulen P, Dirix L, Peeters M, Pauwels P, Wever OD, Lardon F. Abstract 4319: Gene expression profiling of isolated small migratory and invasive breast cancer cells at different times during chemotaxis Cancer Research. 72: 4319-4319. DOI: 10.1158/1538-7445.Am2012-4319 |
0.489 |
|
| 2012 |
Peeters DJ, Eynden GGVd, Laere SJV, Salgado R, Huget P, Dam PAv, Peeters M, Pauwels P, Vermeulen PB, Dirix LY. Abstract 4072: Molecular characterization of single tumor cells isolated from blood samples using immunomagnetic enrichment and dielectrophoretic cell sorting: A feasibility study Cancer Research. 72: 4072-4072. DOI: 10.1158/1538-7445.Am2012-4072 |
0.428 |
|
| 2012 |
Sas L, Laere SV, Peeters D, Marsan M, Schooneveld Ev, Lardon F, Dam Pv, Dirix L, Vermeulen P. Abstract 3919: Novel model to study NFkB driven resistance to endocrine treatment in breast cancer Cancer Research. 72: 3919-3919. DOI: 10.1158/1538-7445.Am2012-3919 |
0.426 |
|
| 2012 |
Lehman H, Daasner E, Vermeulen P, Dirix L, Laere SV, Golen Kv. Abstract P3-10-08: A new in vitro method of growing and studying inflammatory breast cancer emboli Cancer Research. 72. DOI: 10.1158/0008-5472.Sabcs12-P3-10-08 |
0.493 |
|
| 2012 |
Lehman H, Laere SV, Golen Cv, Vermeulen P, Dirix L, Golen Kv. Abstract P3-10-04: Regulation of inflammatory breast cancer cell invasion through Akt1/PKBα phosphorylation of RhoC GTPase Cancer Research. 72. DOI: 10.1158/0008-5472.Sabcs12-P3-10-04 |
0.535 |
|
| 2012 |
Peeters D, Eynden GVd, Rutten A, Onstenk W, Sieuwerts A, Laere BD, Dam Pv, Peeters M, Pauwels P, Laere SV, Vermeulen P, Dirix L. Abstract P2-01-09: Tumor cell emboli in the lung and transcriptional profiles of circulating tumor cells derived from different vascular compartments in patients with metastatic breast cancer. Cancer Research. 72. DOI: 10.1158/0008-5472.Sabcs12-P2-01-09 |
0.476 |
|
| 2012 |
Peeters D, Dam Pv, Wuyts H, Eynden GVd, Jeuris K, Prové A, Rutten A, Peeters M, Pauwels P, Laere SV, Hauspy J, Dam Pv, Vermeulen P, Dirix L. Abstract P2-01-08: Different numbers and prognostic significance of circulating tumour cells in patients with metastatic breast cancer according to immunohistochemical subtypes. Cancer Research. 72. DOI: 10.1158/0008-5472.Sabcs12-P2-01-08 |
0.507 |
|
| 2012 |
Majeed A, Eynden GVd, Bird NC, Laere SV, Dirix LY, Vermeulen PB. 440. The Histological Growth Pattern of Colorectal Liver Metastasis Has Prognostic Value Ejso. 38: 860. DOI: 10.1016/J.Ejso.2012.06.399 |
0.333 |
|
| 2011 |
Van Laere SJ, Ueno NT, Finetti P, Vermeulen PB, Lucci A, Birnbaum D, Robertson F, Iwamoto T, van Dam PA, Woodward WA, Viens P, Dirix LY, Reuben JM, Bertucci F. An integrated analysis of three distinct IBC/non-IBC affymetrix gene expression data sets to study the transcriptional heterogeneity both between IBC and non-IBC and within IBC. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 29: 10571. PMID 28021912 DOI: 10.1200/Jco.2011.29.15_Suppl.10571 |
0.393 |
|
| 2011 |
Trinh XB, van Dam PA, Vermeulen PB, Van Laere SJ, Van den Eynden GG, Tjalma WA, Dirix LY. VEGF-A-independent and angiogenesis-dependent tumour growth in patients with metastatic breast cancer. Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico. 13: 805-8. PMID 22082645 DOI: 10.1007/S12094-011-0737-3 |
0.709 |
|
| 2011 |
Trinh XB, Tjalma WA, Dirix LY, Vermeulen PB, Peeters DJ, Bachvarov D, Plante M, Berns EM, Helleman J, Van Laere SJ, van Dam PA. Microarray-based oncogenic pathway profiling in advanced serous papillary ovarian carcinoma. Plos One. 6: e22469. PMID 21799864 DOI: 10.1371/Journal.Pone.0022469 |
0.627 |
|
| 2011 |
Peeters DJ, Van den Eynden GG, van Dam PJ, Prové A, Benoy IH, van Dam PA, Vermeulen PB, Pauwels P, Peeters M, Van Laere SJ, Dirix LY. Circulating tumour cells in the central and the peripheral venous compartment in patients with metastatic breast cancer. British Journal of Cancer. 104: 1472-7. PMID 21468046 DOI: 10.1038/Bjc.2011.122 |
0.8 |
|
| 2011 |
Dawood S, Merajver SD, Viens P, Vermeulen PB, Swain SM, Buchholz TA, Dirix LY, Levine PH, Lucci A, Krishnamurthy S, Robertson FM, Woodward WA, Yang WT, Ueno NT, Cristofanilli M. International expert panel on inflammatory breast cancer: consensus statement for standardized diagnosis and treatment. Annals of Oncology : Official Journal of the European Society For Medical Oncology / Esmo. 22: 515-23. PMID 20603440 DOI: 10.1093/Annonc/Mdq345 |
0.481 |
|
| 2011 |
Peeters D, van Dam P, Van den Eynden G, Benoy I, Van Laere SJ, van Dam PA, Huget P, Pauwels P, Peeters M, Vermeulen PB, Dirix LY. Detection of circulating tumor cells in patients with advanced breast cancer according to the immunohistochemical subtype. Journal of Clinical Oncology. 29: e21022-e21022. DOI: 10.1200/Jco.2011.29.15_Suppl.E21022 |
0.779 |
|
| 2011 |
Schooneveld Ev, Wouters M, Auwera IVd, Peeters D, Huget P, Dam PAv, Vermeulen PB, Laere SJV, Dirix LY. Detection of circulating miRNAs in serum from patients with breast cancer and their association with the presence of metastatic disease. Journal of Clinical Oncology. 29: 10506-10506. DOI: 10.1200/Jco.2011.29.15_Suppl.10506 |
0.405 |
|
| 2011 |
Eynden GGVd, Fiorentino M, Laere SSV, Peeters DS, Trinh XB, Dirix LY, Vermeulen PB. Abstract 5243: Gene expression analysis of CRC liver metastases with different growth patterns Cancer Research. 71: 5243-5243. DOI: 10.1158/1538-7445.Am2011-5243 |
0.359 |
|
| 2011 |
Marsan M, Limame R, François K, Bertucci F, Ueno N, Lardon F, Pauwels P, Dam PV, Vermeulen PB, Dirix LY, Laere SJV. Abstract 3427: A core invasiveness gene signature reveals reduced EMT in samples from patients with IBC, potentially regulated by decreased EGFR- and TGFb-signaling Cancer Research. 71: 3427-3427. DOI: 10.1158/1538-7445.Am2011-3427 |
0.498 |
|
| 2011 |
Laere SJV, Ueno N, Finetti P, Vermeulen PB, Lucci A, Birnbaum D, Robertson F, Iwamoto T, Dam PV, Woodward W, Viens P, Dirix LY, Reuben JR, Bertucci F. Abstract 328: An integrated analysis of three distinct IBC/non-IBC Affymetrix gene expression data sets to study the transcriptional heterogeneity both between IBC and non-IBC and within IBC Cancer Research. 71: 328-328. DOI: 10.1158/1538-7445.Am2011-328 |
0.382 |
|
| 2011 |
Trinh XB, Tjalma WA, Dirix LY, Vermeulen PB, Peeters D, Sas L, Gert VDEG, Laere SJV, Dam PAv. Abstract 3203: Oncogenic pathways analysis and survival outcome in advanced serous ovarian cancer Cancer Research. 71: 3203-3203. DOI: 10.1158/1538-7445.Am2011-3203 |
0.421 |
|
| 2011 |
Laere SV, Ueno N, Finetti P, Vermeulen P, Lucci A, Birnbaum D, Robertson F, Dam Pv, Woodward W, Viens P, Dirix L, Reuben J, Iwamoto T, Cristofanilli M, Bertucci F. PD03-01: An Integrated Analysis of Three Distinct IBC/nIBC Affymetrix Gene Expression Data Sets Further Unveils the Molecular Biology of IBC. Cancer Research. 71. DOI: 10.1158/0008-5472.Sabcs11-Pd03-01 |
0.384 |
|
| 2011 |
van DP, Verheyden G, Trinh B, VanderMussele H, Wuyts H, Verkinderen L, Hauspy J, Vermeulen P, Dirix L. P5-23-06: Monitoring of Quality Indicators Should Lead to Quality Measures. A Dynamic Clinical Pathway for the Treatment of Patients with Early Breast Cancer Is a Tool for Better Cancer Care: Implementation and Prospective Analysis between 2002–2010. Cancer Research. 71. DOI: 10.1158/0008-5472.Sabcs11-P5-23-06 |
0.446 |
|
| 2011 |
Van dEG, Van LS, Smid M, Martens J, Foekens J, Vermeulen P, Dirix L. P5-14-14: The Presence of a Fibrotic Focus Adds Significant Prognostic Information to the Prognostic 76-Gene Relapse Score in Lymph Node Negative Breast Cancer. Cancer Research. 71. DOI: 10.1158/0008-5472.Sabcs11-P5-14-14 |
0.45 |
|
| 2011 |
Van LS, Van GK, Joglekar M, Ueno N, Finetti P, Van DP, Viens P, Birnbaum D, Bertucci F, Vermeulen P, Dirix L. P5-01-01: Identification, Validation and Assessment of Transcriptional Relevance of a PDGFR-Activation Signature in (Inflammatory) Breast Cancer. Cancer Research. 71. DOI: 10.1158/0008-5472.Sabcs11-P5-01-01 |
0.465 |
|
| 2010 |
Dirix LY, Van Dam PA, Prove AM, Vermeulen PB. Bevacizumab in the treatment of patients with advanced breast cancer: where have we landed? Therapeutic Advances in Medical Oncology. 2: 331-42. PMID 21789145 DOI: 10.1177/1758834010376301 |
0.397 |
|
| 2010 |
Van der Auwera I, Yu W, Suo L, Van Neste L, van Dam P, Van Marck EA, Pauwels P, Vermeulen PB, Dirix LY, Van Laere SJ. Array-based DNA methylation profiling for breast cancer subtype discrimination. Plos One. 5: e12616. PMID 20830311 DOI: 10.1371/Journal.Pone.0012616 |
0.684 |
|
| 2010 |
Van der Auwera I, Limame R, van Dam P, Vermeulen PB, Dirix LY, Van Laere SJ. Integrated miRNA and mRNA expression profiling of the inflammatory breast cancer subtype. British Journal of Cancer. 103: 532-41. PMID 20664596 DOI: 10.1038/Sj.Bjc.6605787 |
0.626 |
|
| 2010 |
Van Laere S, Limame R, Van Marck EA, Vermeulen PB, Dirix LY. Is there a role for mammary stem cells in inflammatory breast carcinoma?: a review of evidence from cell line, animal model, and human tissue sample experiments. Cancer. 116: 2794-805. PMID 20503411 DOI: 10.1002/Cncr.25180 |
0.658 |
|
| 2010 |
Vermeulen PB, van Golen KL, Dirix LY. Angiogenesis, lymphangiogenesis, growth pattern, and tumor emboli in inflammatory breast cancer: a review of the current knowledge. Cancer. 116: 2748-54. PMID 20503405 DOI: 10.1002/Cncr.25169 |
0.465 |
|
| 2010 |
Deschoolmeester V, Baay M, Van Marck E, Weyler J, Vermeulen P, Lardon F, Vermorken JB. Tumor infiltrating lymphocytes: an intriguing player in the survival of colorectal cancer patients. Bmc Immunology. 11: 19. PMID 20385003 DOI: 10.1186/1471-2172-11-19 |
0.395 |
|
| 2010 |
Van der Auwera I, Bovie C, Svensson C, Trinh XB, Limame R, van Dam P, van Laere SJ, van Marck EA, Dirix LY, Vermeulen PB. Quantitative methylation profiling in tumor and matched morphologically normal tissues from breast cancer patients. Bmc Cancer. 10: 97. PMID 20226036 DOI: 10.1186/1471-2407-10-97 |
0.691 |
|
| 2010 |
Van der Auwera I, Peeters D, Benoy IH, Elst HJ, Van Laere SJ, Prové A, Maes H, Huget P, van Dam P, Vermeulen PB, Dirix LY. Circulating tumour cell detection: a direct comparison between the CellSearch System, the AdnaTest and CK-19/mammaglobin RT-PCR in patients with metastatic breast cancer. British Journal of Cancer. 102: 276-84. PMID 19953098 DOI: 10.1200/Jco.2009.27.15_Suppl.E22117 |
0.681 |
|
| 2010 |
Deschoolmeester V, Boeckx C, Wuyts W, Marck EV, Vermeulen P, Pauwels P, Peeters M, Lardon F, Vermorken JB, Baay M. Abstract 2122:KRASmutation detection using high resolution melting analysis and its prognostic value in archival colorectal cancer tissues Cancer Research. 70: 2122-2122. DOI: 10.1158/1538-7445.Am10-2122 |
0.339 |
|
| 2010 |
Laere SV, Auwera IVd, Dam Pv, Vermeulen P, Dirix L. Abstract P6-04-07: Pathway Activation Probability Score Analysis Reveals Patterns of Pathway Deregulation in Inflammatory Breast Cancer Cancer Research. 70. DOI: 10.1158/0008-5472.Sabcs10-P6-04-07 |
0.44 |
|
| 2010 |
Auwera IVd, Laere SV, Yu W, Dam Pv, Pauwels P, Marck EV, Vermeulen P, Dirix L. Abstract P3-04-01: Integrated Analysis of Epigenetic Signatures Associated with Inflammatory Breast Cancer Cancer Research. 70. DOI: 10.1158/0008-5472.Sabcs10-P3-04-01 |
0.454 |
|
| 2010 |
Peeters D, Eynden GVd, Benoy I, Auwera IVd, Trinh X, Sas L, Laere SV, Dam Pv, Pauwels P, Peeters M, Vermeulen P, Dirix L. Abstract P3-02-10: Comparison of Circulating Tumour Cells in Peripheral and Central Venous Blood of Patients with Metastatic Breast Cancer: A Pilot Study Cancer Research. 70. DOI: 10.1158/0008-5472.Sabcs10-P3-02-10 |
0.447 |
|
| 2009 |
Trinh XB, van Dam PA, Dirix LY, Vermeulen PB, Tjalma WA. The rationale for mTOR inhibition in epithelial ovarian cancer. Expert Opinion On Investigational Drugs. 18: 1885-91. PMID 19888868 DOI: 10.1517/13543780903321508 |
0.372 |
|
| 2009 |
Van der Auwera I, Bovie C, Svensson C, Limame R, Trinh XB, van Dam P, Van Laere SJ, Van Marck E, Vermeulen PB, Dirix LY. Quantitative assessment of DNA hypermethylation in the inflammatory and non-inflammatory breast cancer phenotypes. Cancer Biology & Therapy. 8: 2252-9. PMID 19829046 DOI: 10.4161/Cbt.8.23.10133 |
0.658 |
|
| 2009 |
Baldewijns MM, van Vlodrop IJ, Smits KM, Vermeulen PB, Van den Eynden GG, Schot F, Roskams T, van Poppel H, van Engeland M, de Bruïne AP. Different angiogenic potential in low and high grade sporadic clear cell renal cell carcinoma is not related to alterations in the von Hippel-Lindau gene. Cellular Oncology : the Official Journal of the International Society For Cellular Oncology. 31: 371-82. PMID 19759417 DOI: 10.3233/Clo-2009-0482 |
0.631 |
|
| 2009 |
Vermeulen PB, Van Laere SJ, Dirix LY. Inflammatory breast carcinoma as a model of accelerated self-metastatic expansion by intravascular growth. British Journal of Cancer. 101: 1028-9; author reply. PMID 19707200 DOI: 10.1038/Sj.Bjc.6605251 |
0.68 |
|
| 2009 |
Van den Eynden GG, Van Laere SJ, Van der Auwera I, Trinh XB, Van Marck EA, Dirix LY, Vermeulen PB. Two distinct expression patterns of urokinase, urokinase receptor and plasminogen activator inhibitor-1 in colon cancer liver metastases. International Journal of Cancer. 125: 1494-6. PMID 19536843 DOI: 10.1002/ijc.24524 |
0.729 |
|
| 2009 |
Van Laere SJ, Elst H, Peeters D, Benoy I, Vermeulen PB, Dirix LY. Re: Anti-epithelial cell adhesion molecule antibodies and the detection of circulating normal-like breast tumor cells. Journal of the National Cancer Institute. 101: 895-6; author reply . PMID 19509352 DOI: 10.1093/jnci/djp116 |
0.596 |
|
| 2009 |
Van der Auwera I, Elst HJ, Van Laere SJ, Maes H, Huget P, van Dam P, Van Marck EA, Vermeulen PB, Dirix LY. The presence of circulating total DNA and methylated genes is associated with circulating tumour cells in blood from breast cancer patients. British Journal of Cancer. 100: 1277-86. PMID 19367284 DOI: 10.1038/Sj.Bjc.6605013 |
0.676 |
|
| 2009 |
Laere SJ, Vermeulen PB, Dirix LY. cDNA microarray analysis of inflammatory breast cancer signatures. Methods in Molecular Biology (Clifton, N.J.). 512: 71-98. PMID 19347274 DOI: 10.1007/978-1-60327-530-9_6 |
0.467 |
|
| 2009 |
Trinh XB, Tjalma WA, Vermeulen PB, Van den Eynden G, Van der Auwera I, Van Laere SJ, Helleman J, Berns EM, Dirix LY, van Dam PA. The VEGF pathway and the AKT/mTOR/p70S6K1 signalling pathway in human epithelial ovarian cancer. British Journal of Cancer. 100: 971-8. PMID 19240722 DOI: 10.1038/Sj.Bjc.6604921 |
0.744 |
|
| 2009 |
Baldewijns MM, Roskams T, Ballet V, Van den Eynden GG, Van Laere SJ, Van der Auwera I, Lerut E, De Bruïne AP, Thijssen VL, Vermeulen PB, van Poppel H. A low frequency of lymph node metastasis in clear-cell renal cell carcinoma is related to low lymphangiogenic activity. Bju International. 103: 1626-31. PMID 19154467 DOI: 10.1111/J.1464-410X.2008.08272.X |
0.71 |
|
| 2009 |
Trinh X, Dam Pv, Tjalma W, Wojtasik A, Lybaert W, Rasschaert M, Rutten A, Prove A, Vermeulen P, Dirix L. An open-label phase II trial to assess to efficacy of sunitinib as an antieffusion agent in patients with malignant peritoneal and/or pleural effusions Journal of Clinical Oncology. 27. DOI: 10.1200/Jco.2009.27.15_Suppl.E14647 |
0.374 |
|
| 2009 |
Dam Pv, Weytjens R, DeMaeyer L, Dam Av, Alberty J, Verstraeten H, Huget P, Verkinderen L, Prove A, Vermeulen P, Dirix L. A prospective nonrandomize study comparing electron intraoperative boost radiotherapy versus postoperative interstitional brachytherapy in patients having breast conserving surgery and adjuvant external beam radiotherapy. Cancer Research. 69: 5140. DOI: 10.1158/0008-5472.Sabcs-5140 |
0.33 |
|
| 2009 |
Elst H, Auwera IVD, Vermeulen P, Prové A, Dam PV, Huget P, Dirix L. Isolation of circulating tumour cells in patients with metastatic breast cancer by filter technology. Cancer Research. 69: 5026. DOI: 10.1158/0008-5472.Sabcs-5026 |
0.368 |
|
| 2009 |
Auwera IVD, Elst H, Benoy I, Prové A, Wuyts H, Maes H, Dam PV, Huget P, Vermeulen P, Dirix L. Circulating tumour cell (CTC) detection: a direct comparison between the CellSearch system, the AdnaTest, CK19/MAM RT-PCR and unmethylated/methylated free DNA in patients with metastatic breast cancer. Cancer Research. 69: 5025. DOI: 10.1158/0008-5472.Sabcs-5025 |
0.447 |
|
| 2009 |
Auwera IVd, Elst H, Laere SV, Dam Pv, Marck EV, Vermeulen P, Dirix L. Association of serum tumor-related methylated DNA with circulating tumor cells in peripheral blood of breast cancer patients Cancer Research. 69: 5017. DOI: 10.1158/0008-5472.Sabcs-5017 |
0.416 |
|
| 2009 |
Sweldens C, Huget P, Weytjens R, Prove A, Vermeulen P, Dam PV, Dirix L. Brain metastases (BM) in patients presenting with HER-2 amplified advanced breast cancer (ABC). Cancer Research. 69: 1060. DOI: 10.1158/0008-5472.Sabcs-1060 |
0.503 |
|
| 2009 |
Trinh B, Dam PV, Prové A, Maes H, Laere SV, Tjalma W, Huget P, Vermeulen P, Dirix L. Angiogenic escape and tumour progression in two patients with metastatic breast cancer receiving bevacizumab treatment. Cancer Research. 69: 1029. DOI: 10.1158/0008-5472.Sabcs-1029 |
0.483 |
|
| 2009 |
Auwera IVd, Laere SV, Limame R, Trinh X, Marck EV, Dam Pv, Dirix L, Vermeulen P. A microRNA Expression Profile Consisting of 12 microRNAs Is Associated with Inflammatory Breast Cancer. Cancer Research. 69: 6119-6119. DOI: 10.1158/0008-5472.Sabcs-09-6119 |
0.469 |
|
| 2009 |
Laere SV, Auwera IVd, Limame R, Trinh X, Marck EV, Dam Pv, Vermeulen P, Dirix L. A microRNA Expression Profile Consisting of 15 microRNAs, Including miR205, Is Associated with Poor Prognosis in Breast Cancer. Cancer Research. 69: 4062-4062. DOI: 10.1158/0008-5472.Sabcs-09-4062 |
0.424 |
|
| 2009 |
Peeters D, Benoy I, Eynden GVd, Auwera IVd, Laere SV, Trinh X, Limame R, Huget P, Dam Pv, Vermeulen P, Dirix L. Prognostic Significance of Real-Time RT-PCR Detection of Disseminated Tumour Cells in Bone Marrow and Circulating Tumour Cells in Patients with Breast Cancer. Cancer Research. 69: 3019-3019. DOI: 10.1158/0008-5472.Sabcs-09-3019 |
0.424 |
|
| 2009 |
Auwera IVd, Renard I, Eynden GVd, Limame R, Trinh X, Dam Pv, Marck EV, Laere SV, Vermeulen P, Dirix L. Gene Promoter Hypermethylation in Tumors and Matched Affected Lymph Nodes of Breast Cancer Patients. Cancer Research. 69: 1149-1149. DOI: 10.1158/0008-5472.Sabcs-09-1149 |
0.468 |
|
| 2008 |
Van Laere S, Beissbarth T, Van der Auwera I, Van den Eynden G, Trinh XB, Elst H, Van Hummelen P, van Dam P, Van Marck E, Vermeulen P, Dirix L. Relapse-free survival in breast cancer patients is associated with a gene expression signature characteristic for inflammatory breast cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 14: 7452-60. PMID 19010862 DOI: 10.1158/1078-0432.Ccr-08-1077 |
0.803 |
|
| 2008 |
Van der Auwera I, Van Laere SJ, Van den Bosch SM, Van den Eynden GG, Trinh BX, van Dam PA, Colpaert CG, van Engeland M, Van Marck EA, Vermeulen PB, Dirix LY. Aberrant methylation of the Adenomatous Polyposis Coli (APC) gene promoter is associated with the inflammatory breast cancer phenotype. British Journal of Cancer. 99: 1735-42. PMID 18841156 DOI: 10.1038/Sj.Bjc.6604705 |
0.759 |
|
| 2008 |
Deschoolmeester V, Van Damme N, Baay M, Claes K, Van Marck E, Baert FJ, Wuyts W, Cabooter M, Weyler J, Vermeulen P, Lardon F, Vermorken JB, Peeters M. Microsatellite instability in sporadic colon carcinomas has no independent prognostic value in a Belgian study population. European Journal of Cancer (Oxford, England : 1990). 44: 2288-95. PMID 18707864 DOI: 10.1016/J.Ejca.2008.06.043 |
0.322 |
|
| 2008 |
Van den Eynden GG, Smid M, Van Laere SJ, Colpaert CG, Van der Auwera I, Bich TX, van Dam P, den Bakker MA, Dirix LY, Van Marck EA, Vermeulen PB, Foekens JA. Gene expression profiles associated with the presence of a fibrotic focus and the growth pattern in lymph node-negative breast cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 14: 2944-52. PMID 18483361 DOI: 10.1158/1078-0432.Ccr-07-4397 |
0.788 |
|
| 2008 |
Deschoolmeester V, Baay M, Wuyts W, Van Marck E, Van Damme N, Vermeulen P, Lukaszuk K, Lardon F, Vermorken JB. Detection of microsatellite instability in colorectal cancer using an alternative multiplex assay of quasi-monomorphic mononucleotide markers. The Journal of Molecular Diagnostics : Jmd. 10: 154-9. PMID 18258928 DOI: 10.2353/Jmoldx.2008.070087 |
0.335 |
|
| 2008 |
Sardari Nia P, Colpaert C, Vermeulen P, Weyler J, Pezzella F, Van Schil P, Van Marck E. Different growth patterns of non-small cell lung cancer represent distinct biologic subtypes. The Annals of Thoracic Surgery. 85: 395-405. PMID 18222232 DOI: 10.1016/J.Athoracsur.2007.08.054 |
0.36 |
|
| 2008 |
Trinh X, Tjalma WA, Dirix LY, Vermeulen PB, Eynden GGVd, Laere SJV, Auwera IVD, Dam PAv. Anti-VEGF treatments in epithelial ovarian cancer: Is it only anti-angiogenesis? Journal of Clinical Oncology. 26: 14548-14548. DOI: 10.1200/Jco.2008.26.15_Suppl.14548 |
0.432 |
|
| 2008 |
Laere SJV, Eynden GGVd, Auwera IVd, Trinh XB, Dam PAv, Marck EAV, Vermeulen PB, Dirix LY. Inflammatory breast carcinoma signature and relapse-free survival in patients with noninflammatory breast cancer Journal of Clinical Oncology. 26: 11048-11048. DOI: 10.1200/Jco.2008.26.15_Suppl.11048 |
0.482 |
|
| 2008 |
Laere SV, Auwera IVd, Eynden GVd, Trinh XB, Dam Pv, Marck EV, Vermeulen P, Dirix L. An inflammatory breast carcinoma signature is associated with reduced relapse free survival in patients with non-inflammatory breast cancer Ejc Supplements. 6: 105-105. DOI: 10.1016/S1359-6349(08)71577-5 |
0.479 |
|
| 2007 |
van Dam PA, van Dam PJ, Verkinderen L, Vermeulen P, Deckers F, Dirix LY. Robotic-assisted laparoscopic cytoreductive surgery for lobular carcinoma of the breast metastatic to the ovaries. Journal of Minimally Invasive Gynecology. 14: 746-9. PMID 17980337 DOI: 10.1016/J.Jmig.2007.06.004 |
0.391 |
|
| 2007 |
Van den Eynden GG, Vandenberghe MK, van Dam PJ, Colpaert CG, van Dam P, Dirix LY, Vermeulen PB, Van Marck EA. Increased sentinel lymph node lymphangiogenesis is associated with nonsentinel axillary lymph node involvement in breast cancer patients with a positive sentinel node. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 13: 5391-7. PMID 17875768 DOI: 10.1158/1078-0432.Ccr-07-1230 |
0.687 |
|
| 2007 |
Van Laere S, Van der Auwera I, Van den Eynden G, Van Hummelen P, van Dam P, Van Marck E, Vermeulen PB, Dirix L. Distinct molecular phenotype of inflammatory breast cancer compared to non-inflammatory breast cancer using Affymetrix-based genome-wide gene-expression analysis. British Journal of Cancer. 97: 1165-74. PMID 17848951 DOI: 10.1038/Sj.Bjc.6603967 |
0.759 |
|
| 2007 |
Van den Eynden GG, Van der Auwera I, Colpaert CG, Dirix LY, Van Marck EA, Vermeulen PB. Letter to the editor: Lymphangiogenesis in primary breast cancer. Cancer Letters. 256: 279-81; author reply. PMID 17714860 DOI: 10.1016/J.Canlet.2007.07.005 |
0.715 |
|
| 2007 |
Van Laere SJ, Van der Auwera I, Van den Eynden GG, van Dam P, Van Marck EA, Vermeulen PB, Dirix LY. NF-kappaB activation in inflammatory breast cancer is associated with oestrogen receptor downregulation, secondary to EGFR and/or ErbB2 overexpression and MAPK hyperactivation. British Journal of Cancer. 97: 659-69. PMID 17700572 DOI: 10.1038/Sj.Bjc.6603906 |
0.74 |
|
| 2007 |
Van den Eynden GG, Van der Auwera I, Van Laere SJ, Trinh XB, Colpaert CG, van Dam P, Dirix LY, Vermeulen PB, Van Marck EA. Comparison of molecular determinants of angiogenesis and lymphangiogenesis in lymph node metastases and in primary tumours of patients with breast cancer. The Journal of Pathology. 213: 56-64. PMID 17674348 DOI: 10.1002/Path.2211 |
0.773 |
|
| 2007 |
Van den Eynden GG, Colpaert CG, Couvelard A, Pezzella F, Dirix LY, Vermeulen PB, Van Marck EA, Hasebe T. A fibrotic focus is a prognostic factor and a surrogate marker for hypoxia and (lymph)angiogenesis in breast cancer: review of the literature and proposal on the criteria of evaluation. Histopathology. 51: 440-51. PMID 17593207 DOI: 10.1111/j.1365-2559.2007.02761.x |
0.712 |
|
| 2007 |
Baldewijns MM, Thijssen VL, Van den Eynden GG, Van Laere SJ, Bluekens AM, Roskams T, van Poppel H, De Bruïne AP, Griffioen AW, Vermeulen PB. High-grade clear cell renal cell carcinoma has a higher angiogenic activity than low-grade renal cell carcinoma based on histomorphological quantification and qRT-PCR mRNA expression profile. British Journal of Cancer. 96: 1888-95. PMID 17505508 DOI: 10.1038/Sj.Bjc.6603796 |
0.732 |
|
| 2007 |
Van den Eynden GG, Van Laere SJ, Van der Auwera I, Gilles L, Burn JL, Colpaert C, van Dam P, Van Marck EA, Dirix LY, Vermeulen PB. Differential expression of hypoxia and (lymph)angiogenesis-related genes at different metastatic sites in breast cancer. Clinical & Experimental Metastasis. 24: 13-23. PMID 17295094 DOI: 10.1007/S10585-006-9049-3 |
0.8 |
|
| 2007 |
Van den Eynden GG, Neyret A, Fumey G, Rizk-Rabin M, Vermeulen PB, Bouizar Z, Body JJ, Dirix LY. PTHrP, calcitonin and calcitriol in a case of severe, protracted and refractory hypercalcemia due to a pancreatic neuroendocrine tumor. Bone. 40: 1166-71. PMID 17188588 DOI: 10.1016/J.Bone.2006.11.009 |
0.601 |
|
| 2007 |
Laere SJV, Auwera IVd, Eynden GGVd, Trinh X, Hummelen PV, Dam Pv, Marck EAV, Vermeulen PB, Dirix LY. Confirmation of the distinct molecular phenotype of inflammatory breast cancer compared to non-inflammatory breast cancer using Affymetrix-based genome-wide gene expression analysis Journal of Clinical Oncology. 25: 21055-21055. DOI: 10.1200/Jco.2007.25.18_Suppl.21055 |
0.497 |
|
| 2007 |
Van der Auwera I, Van den Bosch S, Van Laere S, Van den Eynden G, van Dam P, Colpaert C, van Engeland M, Van Marck E, Vermeulen P, Dirix L. Detection of DNA methylation in inflammatory breast tumours by a multiplex nested methylation-specific PCR Journal of Clinical Oncology. 25: 21027-21027. DOI: 10.1200/Jco.2007.25.18_Suppl.21027 |
0.33 |
|
| 2007 |
Trinh X, Tjalma WA, Dirix LY, Vermeulen PB, Van Den Eynden GG, Van Laere SJ, Van Der Auwera I, van Dam PA. The correlation of the AKT/mTOR/p70S6K1 pathway and VEGF in human epithelial ovarian cancer Journal of Clinical Oncology. 25: 16081-16081. DOI: 10.1200/Jco.2007.25.18_Suppl.16081 |
0.42 |
|
| 2007 |
Dirix LY, Prové A, Sweldens C, Dam PV, Vermeulen P, Benoy I. Phase II study of docetaxel, carboplatin and trastuzumab (THC) in patients with locally advanced breast cancer Journal of Clinical Oncology. 25: 1062-1062. DOI: 10.1200/Jco.2007.25.18_Suppl.1062 |
0.396 |
|
| 2007 |
Verheyden G, Mussele Hvd, Prove AM, Verkinderen L, Schepper AD, Vermeulen PB, Buelens G, Pooter CD, Dirix LY, Dam Pv. 8015 ORAL Stepwise implementation of an evidence-based specialist breast care nurse model in a Belgian breast cancer clinic: Impact on patient's satisfaction, a prospective study Ejc Supplements. 5: 416. DOI: 10.1016/S1359-6349(07)71519-7 |
0.416 |
|
| 2007 |
Eynden GGvd, Auwera Ivd, Laere SJv, Colpaert CG, Dam Pv, Dirix LY, Vermeulen PB, Marck EAv. 313 POSTER Comparison of molecular determinants of angiogenesis and lymphangiogenesis in lymph node metastases and in primary tumours of patients with breast cancer Ejc Supplements. 5: 60-61. DOI: 10.1016/S1359-6349(07)70331-2 |
0.487 |
|
| 2006 |
Van der Auwera I, Cao Y, Tille JC, Pepper MS, Jackson DG, Fox SB, Harris AL, Dirix LY, Vermeulen PB. First international consensus on the methodology of lymphangiogenesis quantification in solid human tumours. British Journal of Cancer. 95: 1611-25. PMID 17117184 DOI: 10.1038/Sj.Bjc.6603445 |
0.377 |
|
| 2006 |
Van den Eynden GG, Van der Auwera I, Van Laere SJ, Huygelen V, Colpaert CG, van Dam P, Dirix LY, Vermeulen PB, Van Marck EA. Induction of lymphangiogenesis in and around axillary lymph node metastases of patients with breast cancer. British Journal of Cancer. 95: 1362-6. PMID 17088912 DOI: 10.1038/Sj.Bjc.6603443 |
0.793 |
|
| 2006 |
Vermeulen PB, Van Laere SL, Dirix LY. How to measure and report the estrogen (and progesterone) receptor in breast cancer. International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society. 16: 529-32. PMID 17010066 DOI: 10.1111/J.1525-1438.2006.00689.X |
0.429 |
|
| 2006 |
Dirix LY, Van Dam P, Prové A, Vermeulen PB. Inflammatory breast cancer: current understanding. Current Opinion in Oncology. 18: 563-71. PMID 16988576 DOI: 10.1097/01.Cco.0000245307.29026.0A |
0.495 |
|
| 2006 |
Benoy IH, Elst H, Van Dam P, Scharpé S, Van Marck E, Vermeulen PB, Dirix LY. Detection of circulating tumour cells in blood by quantitative real-time RT-PCR: effect of pre-analytical time. Clinical Chemistry and Laboratory Medicine. 44: 1082-7. PMID 16958599 DOI: 10.1515/Cclm.2006.210 |
0.367 |
|
| 2006 |
Van der Auwera I, Colpaert C, Van Marck E, Vermeulen P, Dirix L. Lymphangiogenesis in breast cancer. The American Journal of Surgical Pathology. 30: 1055-6; author reply. PMID 16861982 DOI: 10.1097/00000478-200608000-00021 |
0.481 |
|
| 2006 |
Benoy IH, Elst H, Philips M, Wuyts H, Van Dam P, Scharpé S, Van Marck E, Vermeulen PB, Dirix LY. Prognostic significance of disseminated tumor cells as detected by quantitative real-time reverse-transcriptase polymerase chain reaction in patients with breast cancer. Clinical Breast Cancer. 7: 146-52. PMID 16800974 DOI: 10.3816/Cbc.2006.N.024 |
0.448 |
|
| 2006 |
Van Laere SJ, Van der Auwera I, Van den Eynden GG, Elst HJ, Weyler J, Harris AL, van Dam P, Van Marck EA, Vermeulen PB, Dirix LY. Nuclear factor-kappaB signature of inflammatory breast cancer by cDNA microarray validated by quantitative real-time reverse transcription-PCR, immunohistochemistry, and nuclear factor-kappaB DNA-binding. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 12: 3249-56. PMID 16740744 DOI: 10.1158/1078-0432.Ccr-05-2800 |
0.781 |
|
| 2006 |
Perryman LA, Blair JM, Kingsley EA, Szymanska B, Ow KT, Wen VW, MacKenzie KL, Vermeulen PB, Jackson P, Russell PJ. Over-expression of p53 mutants in LNCaP cells alters tumor growth and angiogenesis in vivo. Biochemical and Biophysical Research Communications. 345: 1207-14. PMID 16723121 DOI: 10.1016/J.Bbrc.2006.05.020 |
0.349 |
|
| 2006 |
Van den Eynden GG, Van der Auwera I, Van Laere SJ, Colpaert CG, van Dam P, Dirix LY, Vermeulen PB, Van Marck EA. Distinguishing blood and lymph vessel invasion in breast cancer: a prospective immunohistochemical study. British Journal of Cancer. 94: 1643-9. PMID 16670715 DOI: 10.1038/Sj.Bjc.6603152 |
0.77 |
|
| 2006 |
Benoy IH, Elst H, Philips M, Wuyts H, Van Dam P, Scharpé S, Van Marck E, Vermeulen PB, Dirix LY. Real-time RT-PCR detection of disseminated tumour cells in bone marrow has superior prognostic significance in comparison with circulating tumour cells in patients with breast cancer. British Journal of Cancer. 94: 672-80. PMID 16495933 DOI: 10.1038/Sj.Bjc.6602985 |
0.423 |
|
| 2006 |
Van Laere SJ, Van den Eynden GG, Van der Auwera I, Vandenberghe M, van Dam P, Van Marck EA, van Golen KL, Vermeulen PB, Dirix LY. Identification of cell-of-origin breast tumor subtypes in inflammatory breast cancer by gene expression profiling. Breast Cancer Research and Treatment. 95: 243-55. PMID 16261404 DOI: 10.1007/S10549-005-9015-9 |
0.78 |
|
| 2006 |
Van den Eynden GG, Van Laere SJ, Van der Auwera I, Merajver SD, Van Marck EA, van Dam P, Vermeulen PB, Dirix LY, van Golen KL. Overexpression of caveolin-1 and -2 in cell lines and in human samples of inflammatory breast cancer. Breast Cancer Research and Treatment. 95: 219-28. PMID 16244790 DOI: 10.1007/S10549-005-9002-1 |
0.799 |
|
| 2006 |
Dirix L, Van Dam P, Vermeulen P. Genomics and circulating tumor cells: promising tools for choosing and monitoring adjuvant therapy in patients with early breast cancer? Current Opinion in Oncology. 17: 551-8. PMID 16224232 DOI: 10.1097/01.Cco.0000183669.61767.81 |
0.484 |
|
| 2006 |
Dirix L, Benoy, Prové A, Elst H, Vandebroeck J, Wuyts H, Philips M, Deleu I, Dam PV, Vermeulen P. Phase II study of Docetaxel, Carboplatin, and Trastuzumab (THC) as first-line treatment in patients with HER-2 amplified advanced breast cancer. Changes in circulating tumor cells (CTC), total plasma DNA and circulating HER-2 ECD Ejc Supplements. 4: 161. DOI: 10.1016/S1359-6349(06)80408-8 |
0.426 |
|
| 2006 |
Laere SV, Auwera Vd, Eynden GVd, Huygelen V, Elst H, Dam Pv, Marck EV, Vermeulen P, Dirix L. Inflammatory breast cancer: at the cross-roads of NFkB and estrogen receptor signalling pathways? Ejc Supplements. 4: 136-137. DOI: 10.1016/S1359-6349(06)80325-3 |
0.417 |
|
| 2006 |
Auwera IVd, Elst, Huygelen V, Laere SV, Eynden GVd, Dam Pv, Marck EV, Vermeulen P, Dirix L. Real-time RT-PCR of CD146 and VE-cadherin mRNA to detect circulating endothelial cells in peripheral blood of patients with breast cancer Ejc Supplements. 4: 126. DOI: 10.1016/S1359-6349(06)80292-2 |
0.432 |
|
| 2006 |
Laere SV, Eynden Vd, Auwera IVd, Huygelen V, Elst H, Colpaert C, Dam Pv, Marck EV, Vermeulen P, Dirix L. Identification of cell-of-origin subtypes and a wound healing response signature in inflammatory breast cancer Ejc Supplements. 4: 125-126. DOI: 10.1016/S1359-6349(06)80289-2 |
0.455 |
|
| 2006 |
Eynden GVd, Auwera Vd, Laere SV, Colpaert C, Dam Pv, Marck EV, Vermeulen P, Dirix L. Distinguishing blood and lymph vessel invasion in breast cancer: a prospective study in 95 patients Ejc Supplements. 4: 122. DOI: 10.1016/S1359-6349(06)80275-2 |
0.5 |
|
| 2005 |
Van der Auwera I, Van den Eynden GG, Colpaert CG, Van Laere SJ, van Dam P, Van Marck EA, Dirix LY, Vermeulen PB. Tumor lymphangiogenesis in inflammatory breast carcinoma: a histomorphometric study. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 11: 7637-42. PMID 16278382 DOI: 10.1158/1078-0432.Ccr-05-1142 |
0.791 |
|
| 2005 |
Van den Eynden GG, Van der Auwera I, Van Laere SJ, Colpaert CG, Turley H, Harris AL, van Dam P, Dirix LY, Vermeulen PB, Van Marck EA. Angiogenesis and hypoxia in lymph node metastases is predicted by the angiogenesis and hypoxia in the primary tumour in patients with breast cancer. British Journal of Cancer. 93: 1128-36. PMID 16251878 DOI: 10.1038/Sj.Bjc.6602828 |
0.776 |
|
| 2005 |
Van Laere S, Van der Auwera I, Van den Eynden GG, Fox SB, Bianchi F, Harris AL, van Dam P, Van Marck EA, Vermeulen PB, Dirix LY. Distinct molecular signature of inflammatory breast cancer by cDNA microarray analysis. Breast Cancer Research and Treatment. 93: 237-46. PMID 16172796 DOI: 10.1007/S10549-005-5157-Z |
0.787 |
|
| 2005 |
Baak JP, Colpaert CG, van Diest PJ, Janssen E, van Diermen B, Albernaz E, Vermeulen PB, Van Marck EA. Multivariate prognostic evaluation of the mitotic activity index and fibrotic focus in node-negative invasive breast cancers. European Journal of Cancer (Oxford, England : 1990). 41: 2093-101. PMID 16153819 DOI: 10.1016/J.Ejca.2005.03.038 |
0.512 |
|
| 2005 |
Benoy IH, Salgado R, Elst H, Van Dam P, Weyler J, Van Marck E, Scharpé S, Vermeulen PB, Dirix LY. Relative microvessel area of the primary tumour, and not lymph node status, predicts the presence of bone marrow micrometastases detected by reverse transcriptase polymerase chain reaction in patients with clinically non-metastatic breast cancer. Breast Cancer Research : Bcr. 7: R210-9. PMID 15743502 DOI: 10.1186/Bcr980 |
0.402 |
|
| 2005 |
Van der Auwera I, Vermeulen P, Van Marck E, Dirix L. Lack of lymphangiogenesis during breast carcinogenesis. Journal of Clinical Pathology. 57: 1342-3. PMID 15563685 DOI: 10.1136/jcp.2004.021626 |
0.304 |
|
| 2005 |
Benoy I, Elst H, dan der Auwera I, van Laere S, dan den Eynden G, van Dam P, van Marck E, Vermeulen P, Dirix L. Detection of disseminated epithelial cells in patients with breast cancer: comparison of blood and bone marrow for CK19 en MAM mRNA expression Journal of Clinical Oncology. 23: 9539-9539. DOI: 10.1200/Jco.2005.23.16_Suppl.9539 |
0.442 |
|
| 2005 |
Nia PS, Colpaert C, Vermeulen P, Marck EV, Schil PV. P-110 A novel biologic classification of non-small cell lung cancer Lung Cancer. 49. DOI: 10.1016/S0169-5002(05)80604-X |
0.334 |
|
| 2005 |
Nia PS, Colpaert C, Vermeulen P, Marck EV, Schil PV. PD-023 Carbonic anhydrase 9 expression profile combined with growthpatterns in non-small cell lung cancer identifies a group of patients with an extremely poor prognosis Lung Cancer. 49. DOI: 10.1016/S0169-5002(05)80356-3 |
0.337 |
|
| 2004 |
Van der Auwera I, Van Laere SJ, Van den Eynden GG, Benoy I, van Dam P, Colpaert CG, Fox SB, Turley H, Harris AL, Van Marck EA, Vermeulen PB, Dirix LY. Increased angiogenesis and lymphangiogenesis in inflammatory versus noninflammatory breast cancer by real-time reverse transcriptase-PCR gene expression quantification. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 10: 7965-71. PMID 15585631 DOI: 10.1158/1078-0432.Ccr-04-0063 |
0.795 |
|
| 2004 |
Benoy IH, Salgado R, Van Dam P, Geboers K, Van Marck E, Scharpé S, Vermeulen PB, Dirix LY. Increased serum interleukin-8 in patients with early and metastatic breast cancer correlates with early dissemination and survival. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 10: 7157-62. PMID 15534087 DOI: 10.1158/1078-0432.Ccr-04-0812 |
0.479 |
|
| 2004 |
Benoy IH, Elst H, Van der Auwera I, Van Laere S, van Dam P, Van Marck E, Scharpé S, Vermeulen PB, Dirix LY. Real-time RT-PCR correlates with immunocytochemistry for the detection of disseminated epithelial cells in bone marrow aspirates of patients with breast cancer. British Journal of Cancer. 91: 1813-20. PMID 15505629 DOI: 10.1038/Sj.Bjc.6602189 |
0.395 |
|
| 2004 |
Sardari Nia P, Colpaert C, Blyweert B, Kui B, Vermeulen P, Ferguson M, Hendriks J, Weyler J, Pezzella F, Van Marck E, Van Schil P. Prognostic value of nonangiogenic and angiogenic growth patterns in non-small-cell lung cancer. British Journal of Cancer. 91: 1293-300. PMID 15328525 DOI: 10.1038/Sj.Bjc.6602134 |
0.349 |
|
| 2004 |
Salgado R, Benoy I, Vermeulen P, Dam Pv, Marck EV, Dirix L. Circulating basic fibroblast growth factor is partly derived from the tumour in patients with colon, cervical and ovarian cancer. Angiogenesis. 7: 29-32. PMID 15302993 DOI: 10.1023/B:Agen.0000037331.14489.0B |
0.371 |
|
| 2004 |
De Raeve HR, Vermeulen PB, Vanderkerken K, Harris AL, Van Marck E. Microvessel density, endothelial-cell proliferation and carbonic anhydrase IX expression in haematological malignancies, bone-marrow metastases and monoclonal gammopathy of undetermined significance. Virchows Archiv : An International Journal of Pathology. 445: 27-35. PMID 15168117 DOI: 10.1007/S00428-004-1028-Y |
0.334 |
|
| 2004 |
Stessels F, Van den Eynden G, Van der Auwera I, Salgado R, Van den Heuvel E, Harris AL, Jackson DG, Colpaert CG, van Marck EA, Dirix LY, Vermeulen PB. Breast adenocarcinoma liver metastases, in contrast to colorectal cancer liver metastases, display a non-angiogenic growth pattern that preserves the stroma and lacks hypoxia. British Journal of Cancer. 90: 1429-36. PMID 15054467 DOI: 10.1038/Sj.Bjc.6601727 |
0.667 |
|
| 2004 |
Van den Eynden GG, Van der Auwera I, Van Laere S, Colpaert CG, van Dam P, Merajver S, Kleer CG, Harris AL, Van Marck EA, Dirix LY, Vermeulen PB. Validation of a tissue microarray to study differential protein expression in inflammatory and non-inflammatory breast cancer. Breast Cancer Research and Treatment. 85: 13-22. PMID 15039594 DOI: 10.1023/B:Brea.0000021028.33926.A8 |
0.715 |
|
| 2003 |
Colpaert CG, Vermeulen PB, Fox SB, Harris AL, Dirix LY, Van Marck EA. The presence of a fibrotic focus in invasive breast carcinoma correlates with the expression of carbonic anhydrase IX and is a marker of hypoxia and poor prognosis. Breast Cancer Research and Treatment. 81: 137-47. PMID 14572156 DOI: 10.1023/A:1025702330207 |
0.384 |
|
| 2003 |
Sardari Nia P, Stessels F, Pezzella F, Vermeulen PB, van Marck EA, van Schil P. Growth index is independent of microvessel density in non-small cell lung carcinomas. Human Pathology. 34: 959-60; author reply. PMID 14562297 DOI: 10.1016/S0046-8177(03)00247-8 |
0.358 |
|
| 2003 |
Colpaert CG, Vermeulen PB, Van Beest P, Soubry A, Goovaerts G, Dirix LY, Harris AL, Van Marck EA. Cutaneous breast cancer deposits show distinct growth patterns with different degrees of angiogenesis, hypoxia and fibrin deposition. Histopathology. 42: 530-40. PMID 12786888 DOI: 10.1046/j.1365-2559.2003.01629.x |
0.343 |
|
| 2003 |
Colpaert CG, Vermeulen PB, Benoy I, Soubry A, van Roy F, van Beest P, Goovaerts G, Dirix LY, van Dam P, Fox SB, Harris AL, van Marck EA. Inflammatory breast cancer shows angiogenesis with high endothelial proliferation rate and strong E-cadherin expression. British Journal of Cancer. 88: 718-25. PMID 12618881 DOI: 10.1038/sj.bjc.6600807 |
0.36 |
|
| 2003 |
Salgado R, Junius S, Benoy I, Van Dam P, Vermeulen P, Van Marck E, Huget P, Dirix LY. Circulating interleukin-6 predicts survival in patients with metastatic breast cancer. International Journal of Cancer. 103: 642-6. PMID 12494472 DOI: 10.1002/ijc.10833 |
0.347 |
|
| 2003 |
Salgado R, Benoy I, van Marck E, Vermeulen P, Dirix L. The importance of the VEGF-load in platelets in cancer patients. Annals of Oncology : Official Journal of the European Society For Medical Oncology. 13: 1689-90. PMID 12377663 DOI: 10.1093/Annonc/Mdf320 |
0.334 |
|
| 2002 |
Van den Eynden GG, Colpaert CG, Vermeulen PB, Weyler JJ, Goovaerts G, van Dam P, Van Marck EA, Dirix LY. Comparative analysis of the biochemical and immunohistochemical determination of hormone receptors in invasive breast carcinoma influence of the tumor-stroma ratio. Pathology, Research and Practice. 198: 517-24. PMID 12389994 DOI: 10.1078/0344-0338-00295 |
0.662 |
|
| 2002 |
Vermeulen PB, Fox SB, Dirix LY, Colpaert C, Van Marck EA. Heterogeneity of vascularisation in invasive breast carcinoma. European Journal of Cancer (Oxford, England : 1990). 38: 1951-2. PMID 12204679 DOI: 10.1016/S0959-8049(02)00156-9 |
0.411 |
|
| 2002 |
Vermeulen PB, Sardari Nia P, Colpaert C, Dirix LY, Van Marck E. Lack of angiogenesis in lymph node metastases of carcinomas is growth pattern-dependent. Histopathology. 40: 105-7. PMID 11903607 DOI: 10.1046/J.1365-2559.2002.1340C.X |
0.314 |
|
| 2002 |
Benoy I, Salgado R, Colpaert C, Weytjens R, Vermeulen PB, Dirix LY. Serum interleukin 6, plasma VEGF, serum VEGF, and VEGF platelet load in breast cancer patients. Clinical Breast Cancer. 2: 311-5. PMID 11899364 DOI: 10.3816/Cbc.2002.N.008 |
0.401 |
|
| 2002 |
Dirix LY, Salgado R, Weytjens R, Colpaert C, Benoy I, Huget P, Van Dam P, Prové A, Lemmens J, Vermeulen P. Plasma fibrin D-dimer levels correlate with tumour volume, progression rate and survival in patients with metastatic breast cancer British Journal of Cancer. 86: 389-395. PMID 11875705 DOI: 10.1038/sj.bjc.6600069 |
0.353 |
|
| 2001 |
Salgado R, Benoy I, Bogers J, Weytjens R, Vermeulen P, Dirix L, Marck EV. Platelets and vascular endothelial growth factor (VEGF): a morphological and functional study. Angiogenesis. 4: 37-43. PMID 11824377 DOI: 10.1023/A:1016611230747 |
0.358 |
|
| 2001 |
Colpaert C, Vermeulen P, Van Marck E, Dirix L. The presence of a fibrotic focus is an independent predictor of early metastasis in lymph node-negative breast cancer patients. The American Journal of Surgical Pathology. 25: 1557-8. PMID 11717549 DOI: 10.1097/00000478-200112000-00016 |
0.355 |
|
| 2001 |
Colpaert C, Vermeulen P, Van Beest P, Goovaerts G, Weyler J, Van Dam P, Dirix L, Van Marck E. Intratumoral hypoxia resulting in the presence of a fibrotic focus is an independent predictor of early distant relapse in lymph node-negative breast cancer patients Histopathology. 39: 416-425. PMID 11683944 DOI: 10.1046/J.1365-2559.2001.01238.X |
0.494 |
|
| 2001 |
Colpaert C, Vermeulen P, Jeuris W, van Beest P, Goovaerts G, Weyler J, Van Dam P, Dirix L, Van Marck E. Early distant relapse in "node-negative" breast cancer patients is not predicted by occult axillary lymph node metastases, but by the features of the primary tumour. The Journal of Pathology. 193: 442-9. PMID 11276002 DOI: 10.1002/Path.829 |
0.465 |
|
| 2000 |
Salgado R, Benoy I, Weytjens R, Vermeulen PB, Dirix LY. Serum vascular endothelial growth factor load and interleukin-6 in cancer patients - reply. British Journal of Cancer. 82: 1896. PMID 11237374 DOI: 10.1054/Bjoc.1999.1253 |
0.397 |
|
| 1999 |
Kumar-Singh S, Weyler J, Martin MJ, Vermeulen PB, Van Marck E. Angiogenic cytokines in mesothelioma: a study of VEGF, FGF-1 and -2, and TGF beta expression. The Journal of Pathology. 189: 72-8. PMID 10451491 DOI: 10.1002/(Sici)1096-9896(199909)189:1<72::Aid-Path401>3.0.Co;2-0 |
0.341 |
|
| 1999 |
Gasparini G, Toi M, Miceli R, Vermeulen PB, Dittadi R, Biganzoli E, Morabito A, Fanelli M, Gatti C, Suzuki H, Tominaga T, Dirix LY, Gion M. Clinical relevance of vascular endothelial growth factor and thymidine phosphorylase in patients with node-positive breast cancer treated with either adjuvant chemotherapy or hormone therapy. The Cancer Journal From Scientific American. 5: 101-11. PMID 10198732 |
0.338 |
|
| 1999 |
Vermeulen PB, Van den Eynden GG, Huget P, Goovaerts G, Weyler J, Lardon F, Van Marck E, Hubens G, Dirix LY. Prospective study of intratumoral microvessel density, p53 expression and survival in colorectal cancer. British Journal of Cancer. 79: 316-22. PMID 9888475 DOI: 10.1038/Sj.Bjc.6690051 |
0.412 |
|
| 1999 |
Dirix L, Weytjens R, Salgado R, Benoy I, Vermeulen P, Prové A, Dam PV, Lemmens J. Plasma D-dimer levels, serum VEGF, b-FGF and IL-6 in metastatic breast cancer (MBC): correlation with tumour load and response to therapy European Journal of Cancer. 35. DOI: 10.1016/S0959-8049(99)80793-X |
0.388 |
|
| 1997 |
Dirix LY, Libura M, Libura J, Vermeulen PB, De Bruijn EA, Van Oosterom AT. In vitro toxicity studies with mitomycins and bleomycin on endothelial cells. Anti-Cancer Drugs. 8: 859-68. PMID 9402313 DOI: 10.1097/00001813-199710000-00007 |
0.305 |
|
| 1997 |
Kumar-Singh S, Vermeulen PB, Weyler J, Segers K, Weyn B, Van Daele A, Dirix LY, Van Oosterom AT, Van Marck E. Evaluation of tumour angiogenesis as a prognostic marker in malignant mesothelioma. The Journal of Pathology. 182: 211-6. PMID 9274533 DOI: 10.1002/(Sici)1096-9896(199706)182:2<211::Aid-Path834>3.0.Co;2-D |
0.371 |
|
| 1997 |
Dirix LY, Vermeulen PB, Pawinski A, Prové A, Benoy I, De Pooter C, Martin M, Van Oosterom AT. Elevated levels of the angiogenic cytokines basic fibroblast growth factor and vascular endothelial growth factor in sera of cancer patients. British Journal of Cancer. 76: 238-43. PMID 9231925 DOI: 10.1038/Bjc.1997.368 |
0.366 |
|
| 1997 |
Vermeulen PB, Libura M, Libura J, O'Neill PJ, van Dam P, Van Marck E, Van Oosterom AT, Dirix LY. Influence of investigator experience and microscopic field size on microvessel density in node-negative breast carcinoma. Breast Cancer Research and Treatment. 42: 165-72. PMID 9138605 DOI: 10.1023/A:1005737524541 |
0.412 |
|
| 1997 |
Dirix L, Vermeulen P, Libura L, Libura J, Pawinsky A, Bruljn EAD, Oosterom AV. Comparison of the in vitro cytotoxicity of the antitumour antibiotics bleomycin and mitomycin on human colorectal cancer cells and endothelial cells European Journal of Cancer. 33: 199-199. DOI: 10.1016/S0959-8049(97)84587-X |
0.365 |
|
| 1997 |
Vermeulen P, Pawinsky A, Marck EV, Hubens G, Goovaerts G, Oosterom AV, Dirix LY. A prospective study on intratumoral microvessel density (IMD), p53-protein expression and prognosis in colorectal cancer European Journal of Cancer. 33: 190-190. DOI: 10.1016/S0959-8049(97)84578-9 |
0.369 |
|
| 1996 |
Hubens G, Pauwels M, Hubens A, Vermeulen P, Marck EV, Eyskens E. The influence of a pneumoperitoneum on the peritoneal implantation of free intraperitoneal colon cancer cells Surgical Endoscopy and Other Interventional Techniques. 10: 809-812. PMID 9171141 DOI: 10.1007/S004649900428 |
0.334 |
|
| 1996 |
Dirix LY, Vermeulen PB, Hubens G, Benoy I, Martin M, De Pooter C, Van Oosterom AT. Serum basic fibroblast growth factor and vascular endothelial growth factor and tumour growth kinetics in advanced colorectal cancer. Annals of Oncology : Official Journal of the European Society For Medical Oncology / Esmo. 7: 843-8. PMID 8922199 DOI: 10.1093/Oxfordjournals.Annonc.A010764 |
0.357 |
|
| 1996 |
Vermeulen PB, Roland L, Mertens V, Van Marck E, De Bruijn EA, Van Oosterom AT, Dirix LY. Correlation of intratumoral microvessel density and p53 protein overexpression in human colorectal adenocarcinoma. Microvascular Research. 51: 164-74. PMID 8778572 DOI: 10.1006/Mvre.1996.0018 |
0.355 |
|
| 1996 |
Dirix LY, Vermeulen PB, Fierens H, De Schepper B, Corthouts B, Van Oosterom AT. Long-term results of continuous treatment with recombinant interferon-alpha in patients with metastatic carcinoid tumors--an antiangiogenic effect? Anti-Cancer Drugs. 7: 175-81. PMID 8740722 DOI: 10.1097/00001813-199602000-00005 |
0.314 |
|
| 1996 |
Dirix LY, Vermeulen PB, Van Oosterom AT, Gasparini G. Microvascular count and prognosis in colorectal cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 14: 2400-3. PMID 8708734 DOI: 10.1200/Jco.1996.14.8.2400 |
0.389 |
|
| 1995 |
Vermeulen PB, Verhoeven D, Hubens G, Van Marck E, Goovaerts G, Huyghe M, De Bruijn EA, Van Oosterom AT, Dirix LY. Microvessel density, endothelial cell proliferation and tumour cell proliferation in human colorectal adenocarcinomas. Annals of Oncology : Official Journal of the European Society For Medical Oncology / Esmo. 6: 59-64. PMID 7536030 DOI: 10.1093/Oxfordjournals.Annonc.A059043 |
0.322 |
|
| 1995 |
Vermeulen PB, Verhoeven D, Fierens H, Hubens G, Goovaerts G, Van Marck E, De Bruijn EA, Van Oosterom AT, Dirix LY. Microvessel quantification in primary colorectal carcinoma: an immunohistochemical study. British Journal of Cancer. 71: 340-3. PMID 7530985 DOI: 10.1038/Bjc.1995.68 |
0.332 |
|
| 1995 |
Vermeulen PB, Libura J, Libura M, Hellemans PW, Van Marck E, Van Oosterom AT, Dirix LY. Re: Tumor angiogenesis as a prognostic assay for invasive ductal breast carcinoma. Journal of the National Cancer Institute. 87: 1797-8; author reply. PMID 7473837 |
0.324 |
|
| 1995 |
Vermeulen PB, Roland L, Mertens V, Marek EV, Bruijn EAD, Oosterom ATV, Dirix LY. 722 Microvessel density and P53 overexpression in colorectal adenocarcinoma European Journal of Cancer. 31. DOI: 10.1016/0959-8049(95)95971-8 |
0.349 |
|
| 1991 |
Dirix LY, Prove A, Becquart D, Wouters E, Vermeulen P, Oosterom Av. Tumor lysis syndrome in a patient with metastatic Merkel cell carcinoma. Cancer. 67: 2207-2210. PMID 2004341 DOI: 10.1002/1097-0142(19910415)67:8<2207::Aid-Cncr2820670834>3.0.Co;2-R |
0.334 |
|
| Show low-probability matches. |